=0A=

[ ACP = Medicine ] [ MedGenMed eJournal = ]

Medscape

Latest
News
CME
Conferences
Resource = Centers
Patient = Ed.
Journals & = Reference
Experts = &=20 Viewpoints

=0A=

Editor's Note:

After relapse, nonadherence rates among patients with = schizophrenia are=20 higher than those for any other psychiatric illness. To find out how to = reduce=20 this problem, Elizabeth Saenger, PhD, Editorial Director, Medscape = Psychiatry=20 and Mental Health, interviewed Peter J. Weiden, MD. Dr. Weiden is = Director of=20 the Psychosis Program, in the Department of Psychiatry, at the = University of=20 Illinois Medical Center, Chicago, Illinois.

Medscape: Peter, you have just presented a poster entitled = "Improving=20 Antipsychotic Adherence in Schizophrenia: A Randomized Pilot Study of a = Brief=20 CBT [Cognitive Behavioral Therapy] Intervention."^[1] What led = you to=20 conduct the study, and what did you find?

Dr. Weiden: Well, the starting point here is that nonadherence = to=20 psychiatric medication is a huge public health problem. As most = clinicians know,=20 patients with schizophrenia will routinely stop their antipsychotic = medications.=20 In fact, nonadherence rates after relapse range from 50% to = 80%.^[2]=20 This is a huge problem because the benefits of treatments do not matter = if you=20 don't take your medications.

Medscape: Right.

Dr. Weiden: If there were an easy answer to this problem, we = would=20 have found it by now. I think that as a field we are, perhaps, better = able to=20 say what does not work rather than what does work. When we look at = psychosocial=20 interventions for nonadherence in schizophrenia, studies of standard=20 patient-based psychoeducation, we see that unfortunately patient = education, for=20 example, teaching about the biomedical model of schizophrenia and the = necessity=20 of medication to control symptoms, does not work; it does not improve = medication=20 adherence. Now, it is important to differentiate patient psychoeducation = from=20 family psychoeducation. Family psychoeducation has been shown to improve = medication adherence for patients with families. So, I want to be very = clear=20 that I'm talking about patient education. While intuitively educating = patients=20 feels like the right thing to do, results of the research have been very = disappointing.

Medscape: Why is that the case?

Dr. Weiden: There are many reasons. First, I would want to = remind [the=20 reader] that nonadherence is a huge problem across all medical and = psychiatric=20 disorders -- it is certainly not confined to schizophrenia by any means. = There=20 is a fundamental difference in schizophrenia compared with other = medical,=20 especially chronic medical, disorders, however. If you have asthma or = diabetes=20 or another serious chronic medical illness, compliance may be a problem, = but for=20 the most part, you are going to acknowledge that you have this illness. = If the=20 clinician designs an adherence intervention, therefore, he or she does = not have=20 to deal with the problem of what to do with patients who say they do not = have=20 this problem.

With schizophrenia, it is very different. The patient who says, "I = don't have=20 schizophrenia. I don't need treatment," is just the kind of patient we = want to=20 reach out to and help with their adherence problem. Yet, there is this = catch-22=20 -- if we set up an adherence intervention for the person's schizophrenia = that=20 includes an educational program for his or her schizophrenia, we run the = risk of=20 turning off the very patient we want to help engage in treatment. That = is, in my=20 opinion, one of the central problems to psychosocial interventions to = improve=20 adherence in schizophrenia -- the lack of insight and not acknowledging = having=20 schizophrenia or whatever name for the psychiatric disorder is used is a = real=20 barrier to engaging people into taking medication.

We think, though, that we have found an answer to this problem, and = that is=20 what we were studying here -- are there ways that we can get around that = fundamental problem?

Medscape: Tell us more about how you circumvent this fundamental=20 problem.

Dr. Weiden: Since we know that many patients [with = schizophrenia] do=20 not acknowledge having an illness, some [of our] research has evaluated = why=20 patients do take their medication. Patients are more likely to take = their=20 medicine if you can find something that helps them feel better from the=20 patient's point of view, especially if you can get the patient to come = up with=20 something on their own; that tends to be a very powerful motivator for=20 adherence. Our work has uncovered another big reason why patients take = their=20 medicine -- their relationships. Research studies have shown, for = instance, that=20 married people are more adherent to regimens than single = people,^[3]=20 because there are many of us, like myself, who if I don't take my = statin, for=20 example, my wife will kill me.

[Laughter]

I am doing it for that relationship. Our schizophrenic patients are = no=20 different; many of them take their medications because of a relationship = -- a=20 relationship with their doctor, with their therapist, or with a family=20 member.

Now, what I had to do, as an adherence specialist, is to look for an=20 intervention that would let me bypass this "you have schizophrenia" = biomedical=20 model. I could not find that in the United States (US). So I turned to = the=20 literature in England where there has been a growing body of evidence = over the=20 past 10 years showing that cognitive behavior therapy, or CBT, modified = for=20 patients with psychosis or schizophrenia (not the same CBT you give to = someone=20 with depression or anxiety) can actually help reduce core symptoms of=20 schizophrenia, such as positive or negative symptoms.

The caveat for these CBT interventions is that the CBT is always = added onto=20 ongoing medication regimens. CBT is not a substitute for antipsychotic=20 medications. In other words, for patients with schizophrenia who have = persistent=20 symptoms and are adherent to their medicine, a course of CBT has been = shown to=20 help reduce symptoms of schizophrenia.

So, I went to England along with 2 of my colleagues, Drs. Page = Burkholder,=20 MD, Professor of Psychiatry, Schizophrenia Research Program, Department = of=20 Psychiatry, State University of New York (SUNY), Downstate Medical = Center,=20 Brooklyn, New York; and Nina Schooler, PhD, Professor of Psychiatry, = SUNY=20 Downstate Medical Center, Brooklyn, New York and we were trained in this = technique. A group there, led by Professors David Graham Kingdon, MD, = MRCPsyc,=20 Professor, Mental Health Care Delivery, Barrow Hospital, Gurney, = Bristol, United=20 Kingdom (UK), and Douglas Turkington, MD, Honorary Professor of = Psychosocial=20 Psychiatry, School of Neurology, Neurobiology and Psychiatry, Newcastle=20 University, Newcastle upon Tyne, UK have developed these CBT techniques. = Professor Turkington has done a study showing that CBT can be taught to = primary=20 care and mental health nurses in England, who can then treat patients] = and=20 improve patient outcome even after a brief course of CBT.^[4] = Outcome=20 measures here included:

Negative symptoms of schizophrenia;
Relapse prevention; and
Insight into the need for treatment, not so much insight = into having=20 schizophrenia.

When I learned of this, I thought "aha!" We can use this CBT program = as a=20 platform to base a more targeted adherence intervention. CBT, as it is=20 practiced, does not insist on the patient accepting a diagnosis of=20 schizophrenia, does not insist on a medical model. And, it is very=20 patient-centered in the sense that a primary technique in CBT for = psychosis is=20 to begin with what bothers the patient -- where is the patient hurting; = where is=20 the patient suffering? To develop a formulation or a treatment plan that = addresses where the patient is suffering from the patient's point of = view.

This sort of approach lines up nicely with my research data that = showed that=20 this sort of approach would, theoretically, be very helpful in improving = adherence in schizophrenia. In theory, this is very appealing. But, we = all know=20 that there is a large gap between theory and practice. But, then we set = about to=20 actually see if we could develop such an intervention, and then test = that=20 intervention center in Brooklyn, New York.

Medscape: How, then, did you translate recognition of this theory = into the=20 practical setting you describe?

Dr. Weiden: Well, we invited Doug Turkington and a colleague = of his,=20 Allison Brabban, PhD, Consultant, Clinical Psychologist, Department of = Clinical=20 Psychology, Shotley Bridge Hospital, Consett, United Kingdom to spend a = week in=20 Brooklyn with us and a group of both senior faculty and front line = clinicians=20 including social workers, psychologists, and nurses received and were = certified=20 in the CBT approach called CBT Insight Program.^[5]

Once we were trained and certified in this program, I then adapted it = to=20 target adherence in particular.

Medscape: Can you describe what you mean? What was entailed in = adapting=20 the program to target adherence in particular?

Dr. Weiden: It was very important for me to make sure that we = did not=20 lose sight of the basic principles of CBT, which include:

Patient-focus;
Goal-orientation;
Not insisting on a biomedical model; and
Staying with the patient's = agenda.

Then I had to merge adherence principles and adherence interventions = into=20 this platform. [I] then retrained [faculty and clinicians in the = adherence=20 aspects specifically], and we conducted a pilot study where patients who = consented to receiving a 12-session CBT program, targeted for adherence, = were=20 randomized to psychoeducation and CBT vs psychoeducation alone. We now = call this=20 program CBT Adherence Intervention or CBT AI to make sure that people = know it is=20 not the exact same intervention as CBT Insight Program developed by Dr.=20 Turkington.

Medscape: What were next steps after the training?

Dr. Weiden: Now, if you want to find patients who are going to = stop=20 their medication, one way to do that is to recruit or enroll patients = who have=20 recently relapsed with schizophrenia and have just stabilized on = medication. I=20 can say that with confidence because a recent relapse and stabilization = from=20 relapse winds up being a huge risk factor that predicts nonadherence in = the near=20 future.

As I mentioned before, patients who have recently relapsed are 50% to = 80%=20 likely to stop their medicine in the near future. By enrolling these = individuals=20 and testing this intervention in a randomized pilot study, I knew that = we would=20 have high nonadherence rates in the 6-month follow-up period. So, this = would be=20 a good test to see whether the intervention of giving patients the = 12-session=20 CBT intervention might help reduce nonadherence. We did not think that = we would=20 eliminate nonadherence, but if we could just slow it down that would be = a=20 [tremendous] advance. Our pilot study [involved] a total of 16 = individuals, 9 of=20 whom were randomized to CBT and 7 of whom were randomized to treatment = as usual.=20 Just one caveat here -- all of these individuals received standard=20 psychoeducation in group settings. But only the patients randomized to = CBT=20 received individual sessions by trained therapists.

Medscape: Can you describe some of the findings?

Dr. Weiden: What we found was very encouraging. We found that = the=20 patients who were randomized to the CBT Adherence Intervention stayed on = their=20 medication longer. This was [in large part] because virtually all of the = patients in the comparison group, the treatment as usual group, had = stopped=20 their medication completely within 4 months. While in the CBT = intervention=20 group, only about half -- actually, slightly under half -- of the = patients=20 stopped. That was a very large difference. Given the small sample size, = the=20 trend level was significant, but had a very large effect.

Remember that the theory here is to not force ourselves or our = message onto=20 the patient. We were not going to lecture at them or tell them why = medicines=20 were "good" for them. We felt that that was not the way to go; [but = rather,] if=20 we stayed focused on the patient's agenda and then brought the role of=20 medication into their agenda so that they could explore it and = understand it=20 from their own perspective, that would be a success.

Interestingly, it turns out that at the end of the sessions, the CBT=20 intervention group reported to us more reasons why they did not want to = take=20 medicine as well as more reasons why they wanted to take medicine.

Medscape: How did that finding affect adherence results or your=20 interpretation of the findings?

Dr. Weiden: Actually, we were very pleased with that because = we felt=20 that if patients could verbalize their reluctance or their concerns = about=20 medicine, that would help them also understand the potential benefits of = medicine in their own terms, as opposed to having it sort of pushed on = them,=20 which they would then reject. We found that the patients given this = adherence=20 intervention were more likely to take their medicine, but were also more = likely=20 to verbalize their concerns and why medicines were not necessarily so = terrific=20 which, of course, we all know that antipsychotic medications are not = perfect and=20 do not fully treat all of the symptoms. We felt that this ability to = verbalize=20 [the pros and cons] was a very healthy step for the [patients], and we = were very=20 pleased by that.

Medscape: I imagine that it gives the psychiatrist a chance to = address=20 those concerns and, perhaps, make changes.

Dr. Weiden: Well, yes and no. Since we were testing a model, = it was=20 very important for us to make sure that the patients given the CBT -- = the CBT=20 group -- did not get extra services or more attention from the=20 psychiatrists.

We worked very hard to safeguard that that was not the case that = adherence=20 benefits are not because the patients getting the CBT also got more=20 sophisticated psychopharm or more basic services.

But, [your question] does call to mind the very important issue that, = when it=20 comes to adherence, there is no one treatment that will work for = everyone. If a=20 patient is taking a medicine that does not work for him or her, or is = having=20 lots of side effects, the CBT intervention probably will not help = adherence. Or,=20 if another patient is so impaired with cognitive problems or with = confusion or=20 psychosis that he or she cannot even find their way to the pharmacy to = pick up=20 the medicine, I don't think that a therapy where they are talking about = goals is=20 going to help necessarily.

One of the things we need to do better as a field is to tailor the = specific=20 adherence intervention or the way to help the patient with the actual = problem=20 that is making it hard for them to take the medicine.

In this case, we believe that a CBT-based adherence intervention is = going to=20 be ideal for a person who:

Rejects "having schizophrenia";
Does not like the idea of a label of mental illness; = or
Does not want a biomedical model teaching=20 approach;

but is still willing to engage with someone to talk about what is = distressing=20 him or her.

Medscape: Did the clinicians like using this kind of intervention? = Were=20 there particular challenges?

Dr. Weiden: That is a very interesting question. If you = recall, one=20 thing that we did in this study was to train front line clinicians -- = all of=20 whom were superb clinicians -- very good at taking care of very ill = patients.=20 But, they were trained in a different type of psychosocial intervention. = They=20 were trained in a psychoeducation model, which involves quickly telling=20 patients:

What their symptoms are;
Why medications are needed; and
Educating them.

While this new intervention, [CBT AI] was very much liked by the = clinicians,=20 and met with a lot of enthusiasm, the hardest part for them was to allow = the=20 patient to describe what they -- the patient -- felt worked or did not = work. To=20 allow the patient to describe why medicines were not right for them, or = why=20 certain other treatments might work for them, or why they did not want=20 medication. The natural inclination, the knee-jerk reaction by the = clinician=20 when a patient is saying something that is clearly "wrong," is to try to = correct=20 him or her.

But, in this case, once you try to correct the patient that ends the=20 dialogue.

Medscape: Right; of course.

Dr. Weiden: That part of the training was the hardest. In = fact, I=20 would joke around that sometimes our biggest tool for this was a large = roll of=20 tape that we kept in the office. Whenever we wanted to tell the patient = why they=20 were wrong or why they were thinking about this [in the] wrong [way], = look at=20 the tape and imagine yourself putting tape over your mouth so you could = then=20 explore further beliefs from the patient's point of view.

The best part is that once we got the hang of it, I think that most = of us,=20 including myself and the other clinicians felt that the CBT AI = intervention=20 helped us learn a lot more about what was going on with our patients. = And at the=20 end of the day, it was a lot more fun for both the clinician and, I = presume, the=20 patient. It made the adherence dialogue less painful, less you-vs-me, = less of a=20 power struggle and more of a dialogue and collaboration.

We were very pleased with that. In fact, we did, along the way, give = a name=20 to this whole process -- the Health Belief Dialogue; Dr. Page Burkholder = came up=20 with this name.

We would like to use this name to move away from the medication = monologue as=20 a contract. The monologue being the clinician droning on and on and = lecturing.=20 We would like to make this a real dialogue, and move it away just from = medicine=20 to overall health and health belief; medicine is one part of that. By = doing that=20 and by freeing up [the dialogue], we believe that this will help = adherence. I=20 say we believe, because I would like to remind the reader that this = [viewpoint=20 comes from] a pilot study. And, while we are very encouraged by these = results,=20 it was not powered enough to give us a final answer as to whether this = technique=20 will really, at the end of the day, prove to be effective in improving = adherence=20 and ultimately helping our patients live a better life.

Medscape: It certainly looks promising and it certainly looks as = if this=20 is something that should be pursued.

Dr. Weiden: Well, thank you very much, and thank you for = giving me the=20 opportunity to explain this to you and your readers.

= Printer-=20 Friendly
Email=20 This

References

[ CLOSE WINDOW ]

References

Weiden P, Burkholder P, Schooler N, Weedon J, Uzenoff S, = Turkington=20 D. Improving Antipsychotic Adherence in Schizophrenia: A = Randomized=20 Pilot Study of a Brief CBT Intervention. Program and abstracts = of the=20 160th Annual Meeting of the American Psychiatric Association; = May 19-24,=20 2007; San Diego, California. Abstract NR803.
Compton MT. Nonadherence in the treatment of schizophrenia. = Medscape=20 Family Medicine. June 22, 2006. Available at:=20 http://www.medscape.com/viewarticle/546619. Accessed June 16, = 2007.
Wroth TH, Pathman DE. Primary medication adherence in a = rural=20 population: the role of the patient-physician relationship and=20 satisfaction with care. JABFM. 2006;19:478-486. Abstract
Turkington D, Kingdon D, Rathod S, Hammond K, Pelton J, = Mehta R.=20 Outcomes of an effectiveness trial of cognitive-behavioural = intervention=20 by mental health nurses in schizophrenia. Br J Psychiatry.=20 2006;189:36-40. Abstract
Turkington D, Kingdon D, Turner T; Insight into = Schizophrenia=20 Research Group. Effectiveness of a brief cognitive-behavioural = therapy=20 intervention in the treatment of schizophrenia. Br J Psychiatry. = 2002;180:523-527. Abstract

[ CLOSE WINDOW ]

Author Information

Peter J. Weiden, MD, Director of the = Psychosis Program,=20 Department of Psychiatry, University of Illinois Medical Center, = Chicago,=20 Illinois

Interviewee Disclosure: Peter J. Weiden, MD, has = disclosed=20 that he has received grant support from AstraZeneca, Bristol-Myers = Squibb/Otsuka=20 America Pharmaceutical, Janssen, and Pfizer, Inc. He has served as a = speaker=20 and/or consultant to AstraZeneca, Bristol-Myers Squibb, Janssen, and = Pfizer,=20 Inc. Dr. Weiden also has disclosed that he has served as a consultant to = Bristol-Myers Squibb and Otsuka America Pharmaceutical Co., Organon, = Shire,=20 Vanda, and Wyeth.

Medscape Psychiatry & Mental Health.=20 2007; =A92007 Medscape

=0A= =0A=

------=_NextPart_001_0017_01C7F153.77CB72F0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://view.atdmt.com/IFR/iview/mdscpefr0120000007ifr/direct/01Andcxb,bdodfizlwAuA?click= ------=_NextPart_001_0017_01C7F153.77CB72F0-- ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://as.medscape.com/html.ng/transactionid%3D1189189926510&site%3D1&pos%3D101&affiliate%3D1&artid%3D558835&pub%3D530&pubs%3D2036&ssp%3D12&cg%3D12

------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: image/jpeg Content-Transfer-Encoding: base64 Content-Location: http://mri.atdmt.com/b/AAIFRWYETEFR/EFX_20070412_unb_def_120x600_15k.jpg /9j/4AAQSkZJRgABAQEASABIAAD/2wBDAAkGBgYHBgkHBwkNCQcJDQ8LCQkLDxEODg8ODhEUDxAQ EBAPFBEUFRYVFBEaGhwcGholJCQkJSgoKCgoKCgoKCj/2wBDAQoJCQ4ODhgRERgZFBIUGR8eHh4e HyIfHx8fHyIkISAgICAhJCMkIiIiJCMmJiQkJiYoKCgoKCgoKCgoKCgoKCj/wAARCAJYAHgDASIA AhEBAxEB/8QAHAABAAEFAQEAAAAAAAAAAAAAAAQBAwUGBwII/8QATxAAAQMDAgIGBgQLBwIEBgMA AQIDBAAFEQYSEyEUIjE1dLIHFTJBUWEjcXPRFiQlUlNUgZGSk6EzQmJjgrHSZHI0RaLBFzZDVpSz wvDx/8QAGQEBAQEBAQEAAAAAAAAAAAAAAAECAwQF/8QALREBAAEDAgUCBAcBAAAAAAAAAAECERID IQQTIjFRQWEUMnGRUlOBocHh8bH/2gAMAwEAAhEDEQA/AN9iQ4qojKlMtkltJJKR8Ku9Bh/oG/4E /dV2C3+JR/s0eUVf4dfMqvf1fPnK6H0GH+gb/gT91Ogw/wBA3/An7ql8Oq8Kp1e6dSH0GH+gb/gT 91Ogw/0Df8A+6pnCpwqdXudSH0GH+gb/AIB91Ogw/wBA3/APuqZwqpwqdR1InQYf6Bv+AfdToMP9 A3/APuqXwqcKp1e5apD6DD/QN/wD7qdBh/oG/wCAfdU3hVThU6vc6kToMP8AQN/wD7qp0KJ7mG/4 E/dUzhU4dOo6mOlw4iYryksoCg2oghI5cqVKnN/iUg/5S/KaV7OGvaXq4e9pXrf/AOAjfZI8oq/i sfCcUIbA/wAtHlFXuKqvNVXu4zVulYpUXiqpxV1M0ySqVF4q6cVdMzJKpUXirpxV0zMoSsUxUbjK pxlUzLwlYqmKjcddV6QumUF4ScU21H6Sqq9JNMoW8KXBP4hJ+yX5TSrU5/MKQPi0vymlevhp2l30 ezzBR+JR/s0eUVf4dUgD8QjfZI8oq/ivLVTu4zTus7KcOr2KYqYpiscOmyr+KbaYmKxspsq/tptp iYrGyqbDUnbVNtMTFH2021I2im0VMExR9tNtSNopsFMTFAmj8Tf+zX5TSr89A6DJ+yX5TSvZw0bS 9GhGyRbmSbdFP+S35RUjgqqtrH5MifYN+QVJxUmiCaYROCqqbDU3FU2is8tMELaaptqbw01ThJpy 0wQ9tMVL4KapwBU5ZgjYptFSOj1TgUwTFYxTFXuGa88M1MTFb2021d4ZpwzTEshXFP5Pk/ZOeU0q 5ckH1dK+xc8ppXfRjZ101bZIxboo+DLflFTUyE1jbcn8nxvsm/KKkbK5TVLOSZxkV6C01Cwar1qu Zkm8qwV01nYLbJMLirmXIf8Al8BtcqR/qQ0FbP8AXisjuUQU55Hly5f1FajabbetFxzGt8ZF2s29 TiuGEtXFO45JVnCJJ+eUq+utRVC3hlmdYvdNhx5tjuEFqe7wIsh/o+N+1S8LQ2+txHJB/u1kFX+P +EidPNNrckiKZkh1ONjKd4Q2lf8AiX1sD5VjJOorX6jk6qhpRL6Ky64jjKU3sLQIcb66VllXLaoB GSe2sHpifeLNZLxq/UjbDapyDclIQpZf2BH4vHUVBKUhCeqlPPmfjWrtN8afeclSGVR3G22dmyQr Zsd3DJ2bVFXV7DuA+WaxadWW5WmZWpNq+gRRKVg7dyxEcW0dnPHXLfV5+8VAumoLtb9B+sJIT6/d itoQ22No6bJ2ttoSk59lxY/dWOvFrZjWbTWhI+FNyXGkzf8AFFggPyVH7RYSn/VVG8tOB1pDm0p3 pCtqu0ZGcGvXKq7k1XKaDzyquBVeVKlhDuqR6smfYO+Q0r1de65n2DvkNK6UtQi21P5Oi/Yt+UVJ 215tafyZE+wb8gqTtrjNLnZH2021f4Ypw6mKWWNtYCbZL6zdJNxsUuO2qeGxKZmtLdSFNJ2JW0pt bZHV7Unl7+RznZdlU2UsWajI0MF6QuNiEsuTLipyRImupAC5Lig4VFCeSUFSQNo91SHbPcr/AAGY moWGoiGXmH3G4j5dRILJ37FBbSNrZUAcZJrZtlNtFa1frbOuGobC3wiq0RHHp0tzPLjsoCYyT7/a cKv2Ug26e7rW53SY0Uxo8ZiFal55KQvL0lWPjv2p/wBNbLtptoLfWplVXNtNtLI8bl1UOKr1im2i o1zezbZY/wAlzymlUuafybL+xc8ppXXTboXrUPyXD+wa8gqXio9pH5Kh/YNeQVLxSw8Ypisbqi9J sVhl3Mp4jjKMR2v0j7hDbLfu9pagK1zS/pDbud0l22Stgs2yAiRMuiCUMOvJVskKY3ZyyhQI357R 8KtizddtMVzSTr29yk7Y0hq3M3Zx2VBmykDEKzxkpQqWtKsblvuZ4SVfEVEt+qtcrVZbPZ902dMX LuK3bjt3C1qUpEJcooSNu4q34SAeQSO2lizq22sPp++t3mM5KCUtMKlSI8E788duOot8VI5e0UKO PhWEvMWXpjTN2vs65yLlfDGU0y4pRbYS89hDSI8Vs7E/SFPPmr/FWF9F8OAzYhqS7Sm3H7RGVGbh j/yxllJ4wUg4Ifd2lTisfIdWlizov4507h8JHQeFu4+88Ti7vY4e3G3bz3bv2Vf2VpJ1fcLL6Njq i7DiXGUFSIsVfIBUtwmKwAMEhCFJz7+RqBqCbraWzapjshVmNwnxI8GzRyOKUKVxHVy3ilR/skqO xHJPvKqWLNrvOrtNWSSiLc5yGZCwFcIJW4pKCcb3OGlXDRk+0vA+dZnbXHvWT9s0VdXJthnSr/JW ZV+kSm+jx+MHfomy6sjitp6gS21kKHLkCa6jpa3Trbp23wrhIXKnNMp6S+6orUp09ZfWPMgE4Hyq Ylk8ppirtMVLJZAug/Jkv7BzyGlXbsB6rmfYO+Q0rdLUPVpH5KhfYNeQVLxUa0d0wvsGvIKl1RjL 7p606gt6rbd2OkQlKStTW5SOaDuHNBSf61AuGgdI3FUEyra2pNuTw4rScobDeQrhqbQQlaNwB2qB Ga2KlBgrxonTF7uES4XSCiTJhJ2Mbidm3O4JUgHasA8wFA1PYtEFi5Srm0jEyYhpp9zJOUMbuGAO wY3nsqdSgg3OzwLohhua3xERn25bSdxA4rJ3Nk4I3AHng8qx150Rpi9OLenQk9IdTw3n2iplxxGQ ShxTRTvScdis1n6UGPn2K13ByE5MYDptzokQ0kkJQ6ElCVbAdp2g8sjl7qpPssObNhXBwfjlu4qo SjkoSt5vhKKkAjdyNZGlBpuobbq68cGySI0VdrclxnpdxacU3+LsOpfU0YywtQWotgAhah8cVuGK 9UoPOKYr1SghXYfkqb9g75DSvV37pm/YO+Q0qwqto7pheHa8gqXUS0d0wvDteQVMoKVhJuoHW9VW /T0RjjreZdl3B0nAjx09RtXzLjvVA+RrJ3KUIlulSy4loMMuOl1wFSE7ElW5QBBIGOeDXPtJO3e1 WS5ekTU0xH5TYE96AyyElLaEYitJcWtZxsI2p9xVzJ50HSaVzrSN31Tc9WtGZO4yUxXHrxbmAgRI Bf2mJGzjeqQNqy4SflW9XZKF2yS2uWYAdbU2JiVBCmlOdRK0qVyyCeXzoFwu1qtiA5cpseGhXYqS 6hoH9qyKljmMjsrnujrBYId0l2O+WyNI1NGaRKcuT+6UZkZSihMgLlFxbZ3IwtGcA9nKsc1q+/6i v9rftk4sxJc9PQLSwEbl2yM4RLnTVKBUEuBJS0kEe7tNBvy75jVLVgQ1uJguT3nt3sAOoZbTtx/f yv3/AN2sotSG0KWtQShI3KUo4AA7STXNFXabtueoIbvDm6iu8ex2d/AUG4kVZaW6N2cA7ZDn7jWX lSE65kqhsZ/AyGvdOljOLi60f/Ds47WEqGXFj2iNo5ZNButK5Imb6RtcK6dZ+PaLQ4r8kyG5DLUc MpVjjPpSHXnnFbSOFhKU+811tOQACcn3mgUqtKCHd+6Zvh3fIaUu/dM3w7vkNKBaO6YXh2vIKmVD tHdMLw7XkFTKCNc4DFytsq3Sc9HmMuR3tvI7HUlCsH6jWChaXnu2NentRyY9ztHAEUbGFsPLSnGx Tig8pIIAHspHPnyrZqUGPsdgtFggJt9ojJixUndtTklSj2qWpWVKUfiTUqVEizIzkWW0h+M8kodZ dSFIUk9oUk8jV6lBirTpawWdT67fDS05JCUPuKKnFKQgYSgqcKjtA7E9lYtjQ9s09YrqxpCI3Duk th0MvrUpSuKUkNZcWVKCUk8h2CtppQayNA6flabtFiukUSI9qS0W0BS0Diob2KUdhTkK3HIPb762 JhhmOyhiO2lphpIQ22gBKUpHIAAcgBVylBgoeiNLQbkq5RICWpSll3ktzhBw9q0MFXCSr5pSDWdp SgUpSgh3fumb4d3yGlLv3TN8O75DSgWjumF4dryCpdRLSQLRCJ7BHa8grnXpH1C8plMeO/0cXF5N ubfztDbbgPFdzyGdgVj54rVNNx0/cnbuyNvbn3VGeukBn+0eTn4Dn/tXIHZzVx6BDt7hTpyxKS+9 OCiGvxVBCGWlf3wO1ZHLHLtrHxbher1ZZN4u7qoNib40hllnLT77IypAW4OaUbeXV5q+OK3y1s68 /qmKnky2pZ+J5CoS9WSSopQ2gH4dprkOn4+pJrsS2Q5i4cC3QkNXB8dZRkScPrSjdkFaUkDcc7ef xrI6iaVYY8W22PZFk3VxSZFzkuELPDTuIVIUFniOZwgns54rUU0+FdLVqyWhBUtLaUjmVHkAKxDH pNhS7gmDEmtPyV5CUsJU4jqjccuIBQMD4muds6VtZjrRPujCH5bqOitNLVIjCRHBVh0yFKDylBfW CtufcKyo1YmNo524MMMtyGHDBaQ3gRlPhfCC2zyHC/vfVyq2jwOjN6nnJ9tKF/0qNp7Xr1xVcVyW AI7MxyNELfvQylCVFRJ5/S7+yuYWuY9CZul/alvTozUXo6ZbylES5xXyUy2eqltKiG07R++pKJzG nZtstL76uHboKn3WWusuVLkr2JQlsc1HPEV+3n8aWpHX/wAL7Ih5hh97gvyVFLDa+1RSkqOPqAqb 67tmcccc643cF3O3WyXqme0n1xsDUOOes1CacWE9YjtPPc6r5Y7BWJhxnrYtWpbncWJEqE2txbca Sp5clTv0SAsnahDe9Q2pS3y+NZmiEs+gm5cVz2HUq/bWK05fX7zJvB2IEKDOXBiuIzlzgoRxVHPL k4VJ5fCuMlm5XaShMOY89fEuBUq5MOLTAgoz12Wkg7HVberjmT2kit6tLXqiCzBgrW2wyMDrHJPa VK+JUeZPxqcq5Zvd37pm+Hd8hpWHivzpFkuLkhe9rgOhGe3Ow5pXOqLSisufwNPwY6D9I9HaB+Sd gz++tZlQ4kxrgy2G5DOc8N1IWnI7DhWRW8W+LHkWiCH2wvEdrGf+wV7RZbYhW4MJz8+ddKNSIhbt IFvbkRzEEcOR1J2FjZlBR2bdvZip34JPzohiPx0dDWnYppzknb8NtbqlCEDCEhI+QxXqk6xdq8XR TTHE2LQ1xVcR3hpxuWQBuPzwBXqVomHLZLElSH2Fe0062FpP+lWRWzV5U4hPtKA+s1nmVF2up0La Oi9DUlJijkGOGjh/wYxVuToK1vw+glKFQ8AdHW2kt8jkdXs7azy7nb0e0+j9+aom625RwH0/vq5V DTbz6PZksW9qM60iLBktyFMJG0KSyDsQB2DCsH9lVe0q4iYJy4KFzEo4aZISlTgR27QrtxzrdDcI QGeOj+IV6RLir9l1B/1CrzKi7RlQpCgpCmFKTjC0lORj51A9R2pqM7DEBluK9/bMBpKUK/7kgAGu m15U00v20JV9Yq872LudsR2IzKWI7aWmUDCG0AJSB8gOVSYsZcmQhhv2lnH1fE1uTlotrntMJ/Zy /wBqpEtMOI8XmU4URjnzx9Va50Ld4nR241ilMt+yiM6P/QedKuXfumb4d3yGledlCi3eFDtkJt1R 4nRmjtAz/cFW3NVRx/ZsqV9ZxUabA4tigykDrtR2t/zTsH+1cll3hu+qUsqeloeK0WqzwXFNqWlC ijpUt1sp2JKhkbjgD3E11pppsroknXtxVqJq0xmWg10VcqQs5Kk9dKGgOeOt1v3VM/CK6c+uOf8A hrnchu5aX00uUp9Mi/TVsMybg/8A2TalYaSpZxybaHy7eeOdWtNWdcSau9T7kypyKytUpLEhcgrC xkuSFqIGBsO1KUAV0iI8K2a5+kBbXG2ibNajbukuxG9zTe328rJQDtxzCc4qczMExhuS24XGXkJc bXk80qGQefyrntumyrxbHrTbVYk3l9cmctHNuBCcAQlGRy4imkABPbzOcVPjxrzc75Jh22W5b9N2 1tFt3Ne2tbWCsNZ5JUPZK8cvdViRugUkkgHmO0VRx1tpBcdWENp5qWo4A+smtL1E25aeh2Gw8KB0 /iOyZjzpaU7w9u5AkELVxVBXaeeOyojWk7aI4TIuUfpj7pkQmcqfghUZO1xB46l8XOevkhXvGMVc htsPU1inTehQpaZD+Cr6IKWjCe36VILf/qqjuq9Psy0Q+nIXKWoNhpnc8oKUcAK4QVt5/GoCZVrv WikvXBPq+2yx0Zam+q2haXOGNiwNuzenkTy+NU0xPjxY1ygLSwlFlx0iXFQlthaFIK95SjqpWADv HxpkNoan3diUhTEnbFCVcRoglRXkbSFbsAAZ5YrLM6omo/tUpc/pXNfXVwtej1Xh/q3G7P8AEjJf OENGUrDAO7kEoaAVWGbuk63RJtztkh+c5M4Vvt7r+5apkzcVOvttK5JbSCUpwMcqzOI7c7q+IzFc fXHdWptJVwmhvUrAzhI5ZJ91ajd/SDrBq2vXhqLDt0dlTYjWyVvkTZanFhCWwWlIQ2pWewbyP2Vq N9h3IyLU7cn3Hrm/LQ63b4qlJYbZjAvupQkY4i8J27lfHkBWdsFvnuXKNqK+4VNZPEh27tZig+Z7 Har3HsrE6ceiWdRupJs0wqG1RjOZT8OoeXKlebi8h+xynWzlC4zpH8BpXFHu0gKtEMHmDHaBH+gV qg0gi3yn2rXCQ0y4riEtISgKzz62MZNbXaO6YXh2vIKmVqmqw1D8FZr7ZbfS3w18loX1gQe3IqFc /Ri3IsxtUFxmDHeda6ShloISWQ4kvJAQB1lIGK3ylWdSZW7X42i7XFHDj/Qs9vDbSlAz7z1akw9L WSGFBmOAFrU6v5rWdylHHvJ7ay9KmcogSbDZJjHR5kCPJYznhPtIdTn47VgirjlqtbsNMF2GwuEn G2MppBaGOzCCNvL6ql0rItCLFEfooZR0YJ2BnaNm3s27ezGPdUb1HZhAdtqYLCID4Ul6MhtKG1BX JWUpAHOp1KCFPs1puMToU+GzJiHb9A62lSOrzT1SMcsVEkaTsT6mV9FQ25Gz0daEgcPI2nZ+bkcu VZilWJGqXLQzchXGYeCJbaHERpCkgra4owopzke4doqOzpm7tNttL+mWlISp4lI3EDBUcYHPt5Vu dK3GrK3YRMOTD0/OafUD9C8Uge7qGlT7v3TN8O75DSsTN0LR3TC8O15BUyodo7pheHa8gqZUClKU ClKUClKUClKUClKUClKUEO790zfDu+Q0pd+6Zvh3fIaUC0d0wvDteQVMqHaO6YXh2vIKmUClKUCl KUClKUClKUClKUClKUEO790zfDu+Q0pd+6Zvh3fIaUC0d0wvDteQVMqHaO6YXh2vIKmUClKUClKU ClKUClKUClKUClKUEO790zfDu+Q0pd+6Zvh3fIaUC0d0wvDteQVMqHaO6YXh2vIKmUClKUClKUCl KUClKUClKUClKUEO790zfDu+Q0pd+6Zvh3fIaUC0d0wvDteQVMqHaO6YXh2vIKmUClKUGmXG/SYe tEsPSi1bU7eIg+xzaz/vXnV2qm+jx/U0/wCk3ni8I89uOWcivF0sz03XCVPxHHbcvaHHNi+Hya/P HLt+dedY6XjsRo5s8BZcKzxOCFuHGOWfar5lc62OpbtlPm/6OE5Wn6vWrLxc4zlsRHlqjh9lJdUP icdY1kdP8c3DrX9FxSEKzGTjP/d2nsrFavt89521KahvSENMJDqW21K7MZScA4rJaedY9ZJS1p92 3FSVAyVJWABjODlI7cVaZnnTfzH4v42+6x8y1oi63GdLuCJb6nktbeGFe7JV91XteXKdAiRVw3lM qW4oKKfeMVgLE/frHJlrRaJD/HIHNtxONpP+A/Gp2pzd7zZYb3q55uQHl7mEoWpQGORI2g86zGrP w8075/r58pl0e6LIvd6tEiG4m6puSXwFORxtJA5dU9uCc8jXRKwlr0tY4oYkphhMpKUqysrVheO3 askA5+VZuvZw2nXTfKe/aLzNvu6URMFKUr0Nod37pm+Hd8hpS790zfDu+Q0oFo7pheHa8gqZUO0d 0wvDteQVMoFeXHG207nFBCfio4H9a9ValRmJcdyNITvZdG1aT8KSPaHEOJ3oUFIPYoHI/fXlp9h3 PCcS5jt2kH/aubyze7G7I00wve1NUno6v721w7er8N3sqqfqCMvTmnI9uiqw7LWTLfTyKto5pz8O f7vrrxfGTaZx+Xv9fDlzPbs3YT4Jd4IkNF3s4e9O7P1ZzVxx1ppO5xYQnsyo4H9a0mRoO3tWNcpM hfS22S8V5HDJCd2MYzj9tY6RcZM7Q4EhRWuPLS0lZ5kp2FQyflnFJ4qqn5qbTa8bnMmO8OkBaCje FAoxnd7sfXXhMmOpBWl1BQn2lBQwPrNYq1KT+CLKsjAh8z9SOdalp/8A+UL3+z/aulfE2tt3pmft DU1/8dATNhqO1L7ZJ7AFp++r9ce3WX1JhTbvrYr6jg/s9uR28/h8q6fpxM1NjhiaSZOzrE8zjJ2Z +e3FZ4biuZNrel/6SjUuyVKUr1uiHd+6Zvh3fIaUu/dM3w7vkNKBaO6YXh2vIKmVDtHdMLw7XkFY 6brOyQpTkV9TnFaO1eEZGazXqU0/NNkmYhnaVj7TfbbdkKVCd3lv20EFKhns5Gox1bZRcvVpcV0j icHO3q784xu+vlU5tFom8WkyhEvWnJ0/UcC6MraEeLweIlZVvPDdLhwAkjsPxrJX2yR7zBMV47FA 72nRzKVf+4+IqzddU2m1SejS1LDu0L6qcjB//wAqH+H+nvz3f5ZrhM6EZRMx1d92enf3Yv8AA7VK megruifV45bdzh6vw247PlurOp0rbxYTZsnYeuXv73E7d/8A/fdV78JbX05iDuX0iSlC2ht5YcG5 OT9VWJ+sbLAluRJCnA80cKwjI5jPb+2s00aFF5v7bz+yWohghovUqGTAauaPVyu1G5Y5Ht6mCP2b qzLelkxNOSbTEWFPyAdzznIFZx8N2BgVfj6rtEiFJnNqXwIm3ikp59bkMCpdqvEC7MF+EvclJ2rS eSgfmPnV09LQ9JvMx59PYimlhGdIvHSy7RIU2ZQWp1lxJJSlXu5lIPyPKsrpyDcbfbEQ5623Fskh pTZUfo/cDuSns/2rwzqe1POTG0KXugoccf6v91rkrHxqF+H+nvz3f5ZpTyKJicoja3c6YbJSsNbt W2a4LdQw4ocFtTzinE7UhCcAnP7ajN68084/wd7gBOA4UHaf/f8ApXb4jT/FG7WcMtd+6Zvh3fIa Uu/dM3w7vkNK6tFo7pheHa8grRFruCNbTTb46JUncv6JwgJxgZPMpre7R3TC8O15BUWPpyCxeXLw hbpku7tySU7Oty5Dbn+tefiNKa8belTFdN7NagQrhp5m5X+4JQxIdQpDEZBBHEdXuHJJIwD2DPZm tazbPUynC8fXJf4g5K9jsxu7M5O6um3ywxb0021KddQ20orCWikZPZk7kq7KlJt8IRhF4KeCEcLb gezjbj91eergpnaPliNr77z3lidL7MXa3oN7sqJ77DTsnhlt1S0JJC0Dn2j9v7awPo7hxJDM4yGW 3dqm9vESFY5K7M1s1m07Es7LzEZ15bT/ADUl0pODjGU7Up7arY9PQrIl1MVbiw8UlXFKT7OezalP xrrGjVNVFVURtE3axm8NZuaUp9IMJKRhI4QAHYBtNRJYuB13J9XJbXKz1UvexjhDOf2Vt8jTkF+8 t3ha3RJa27Ugp2dXlzG3P9aiXDRVrnz3Zzj0hDzpyrhqQByGOWUE+741yr4ave35mXf0Zmif3RLo LyNLXL1q2y251OHwOzG5PbWsWtF1ssSPqGJ9JGcKm5Dfu5KKcL+RxyPuNbtH0hb2IUuEH5C2pgQH CtaSocMkjb1PnzqdbrNDgW31ajLsbrZD2FZCzkg4AHv+FWeFrqqie1qfN97mEzP6NP0M43Lv1ycK fo321qKFc+S3AcH99PSNEix/V/R2UNbuNu4aQnOOHjOK2ezaWt1nlOyYinSp1OwoWQUgZ3csJB93 vNer7pyDfOB0tbqOBu2cIpHt4znclX5tPhq/h5o2yv8AyYThb1e7harT6vktqQ1EbdbLa30pSjaD 7yeXLOK04SLjpdLcG4NMT7O+oqbxg57MqT788/f+w1v0uIxMjORZCdzLo2rGSOX1isDH0DYWJCX/ AKV0JOQ04oFH9Egn99dOI0apmJotE+f69Wq6Z9GXuqgqzzFDsMd0j+A0qt37pm+Hd8hpXrdC0d0w vDteQVMqHaO6YXh2vIKmUCuUL9KusZms7npew2SNMfgOPBJcfLRU2yrZuJUQnPMV1evmtDNue9L+ okXG+Pafj8aX+PR3+jrJ4o+j3/BXw+VB1n0cekp/Vsu42yfbvV9zthw8lK+I2esUKHYMEKHz+utO tHpt11eo02Va9NMymLekOTFNuq+jSoKIOCQT7Cuz4VF9CNxVC11ebBbHRcrK6HHjcuFtcUWlAIWp ftEHeRgnt5j31p/o40zqK+WPUyrFdH4T8VlguQmdwE0LD/0SilScckkDke2g7JavSw1d/R/c9URI nDnWsESILisp3jBBCwASlQPw++sHZPSl6Tr9BFwtGk2ZUMqKA6l/A3J7Rhaga1vRc+zu+hTVEGK3 wrmwkrnZVuLgcxw3B8BhJTj5fOsFohrS6rEk3LWs2xyuIvMCOXtgHuV1OXWoO/6o1SNN6Rfv05oC QyykiNntkOYCWs/955/LnWp+jP0uvauvEi0XKE3AlBkSIgQpX0ie1Q6/v2qChj3ZrUfTLfJGprrZ dG6f33D6NEtaWzguuON7mvaxjDOV8/zqw2rH9V2DUdl1i9ps2Fq38CGlCXkuodDKVANkp5p3MAo+ oUHU9c+kqdpnV9msDENp9m58He8tSgpHFfLJwBy5AZqxePSnOd1q1pHSUFq5ygSibJdWpLTSh7fN Geq2PaPx5DnWj+mJ2PetdaSdhvqTHuEeKpiS0cLSl6Sdq0H3KAVkVa0VOc9FGvJdk1G2joVx2pRd dvYjJ4boUefDUeTg9x+qg+gxnAz2+/FVqgIIBByDzBFVoId37pm+Hd8hpS790zfDu+Q0oFo7pheH a8gqZUO0d0wvDteQVMoFYeTo3SEp9yTKsdvfkOqK3XnYjC1rUe1SlKQSSazFKCHbbPaLU2pu1wY8 FtZytEZpDIJ+YbArxbLFY7RxPVVviwONt43RWW2d+3O3dw0pzjccZpfY1xl2abGtj4i3F1laIsk9 jbhHVVyB7D8q4JreX6WNGy4EWdqdUhdw3cIsKOE7ClPW3oT+fQd1a0ppdkSA1Z4LYlp2SgmMyOKk ncUuYT1hnnzqP+AmiP8A7etn/wCFH/4VpAtHpL01p7UNzvmoRODdteMPhFW5p9OFBwbkJ7ADUf0V +lS1fgyr8Lb6j1p0lzHST1+FtRt7B2ZzQdKjaa05EmCdEtUNiakbUyWo7SHQNuzAWlIV7PLt7Kk3 C2W25x+jXKKzMjZCuDIbS6jI7DtWCMiuTejDWl5v3pQ1BEcuS5ljQia7b2ifowgS20sqRy/Rq5Vp mj9Warv/AEv1lrz1H0fh8LpW08bfv3beaPY2jP10H0CdLaYJjKNoglUMAQz0Zr6EBW8Brq9TCjnl 76u3OxWO7cP1rb4s/g54XSmW3tm7G7bxEqxnAzioWiw+NMwuPdk3x3DhN0R7LwLqyMYJ9kdXt91Z ygtsR2IzDceO2llhpIQ002kJQlKeQSlIwABVylKCHd+6Zvh3fIaUu/dM3w7vkNKBaO6YXh2vIKmV DtHdMLw7XkFTKBSlWZUuJDZL8t5uOyO1x1QQkftVgUF6uN+nexXy6XjTrlst8qa2zxeMqMy48EZW 0RuKEnHZ766xHvFpksrfjTY7zDfNx1t1CkpHzUkkCr0aXFlILkV5D7YO0qaUFjPbjKc/Ggw2vo0i Voq9xorS35DsJ5DTLSSta1FBwlKU5JJrnPon9FljmaXU9quxLTdOkuJAlh9hzhBKNvUyjlnPPFdd anwHnlR2ZLTj6M72kLSpYwcHKQcjBqy/fbJHkdFkXCM1J7OC482lf8JOaDkfop0tcrJ6VdRLNrkw rMG5rMB5xl1LJb6Y1wkturGFZQnI58xzrStFWafZemev9AXG98fhdH3RpDfC2b9//wBJWd24fur6 YkToUZCVyZDTKF+wpxaUg/USRmryVJUApJyk8wR8KDAaFfQ/pmKW7O5YW0lxCLW8FJW0As+5aUHr e12VsFQl3uzIUULnxkrScKSXkAgjtBGakR5UaU3xIzyHm843tqCxn4ZTmgu0pSgh3fumb4d3yGlL v3TN8O75DSgWjumF4dryCplQ7R3TC8O15BUygV8+SrdI9JfpfuVnu0xyPbLWqQhtlBweFGcDO1oK yApwncTg8q+g65brb0P3CfqI6p0lcxa7ws73UrK0oLmNpWlxsKUncPaG0g0GVsfoa0pYb2xdbap8 bG3WX4r6g606282WyDkA+/6vlXM9VjUXoivdwj2F3Fkv7KzC3ZPBUCAdvv4jO/APvBGcns6LpDRv pHj39i7as1EiaxGS4EQY5WW1KWgoCldRhIIznO0149MHo4vmt/VPqp+Kz0DpPG6UtxOeNwtu3htu foznNBqU3T8/0aeiqVPQSjVF6caZmSk+3HQ5lXDQv3EAEEj+8fkKv6A9COmLxpeJeLzIkSZdxb4/ 0LgQhsK7B2KKlD359/urq+qNN2/U1jk2a4Z6PIA66PaQtJ3IWn5giuW2/wBFfpZsLa7dp/VDDVoJ JSFlxChu7SlvhPBBPb1V9tBjPTPptjTGhNO2OO8uQxElyuG67jeUuFToCscurvxXbLF3Hb/Cs/8A 601zfV3on1PedG2Wxt3RmZcbe8+/LnTVOp4pfUpfIhL6jjfjn8P2Ve05pL0zwLnb/WOoYb1mjONi RGbJ3KYRgFCcxU/3R+cKDksX8HPw51B+EFqmXaN0mVwmYBUFpX0g9ZW1SeWMiu+ei5uxI0uDYrfJ tkJb7iuizSS7v5JKusVcjgYrR4Xou9KFk1Ndb3p652yOq4uvH6UuLPCcd4oBCoygD2dlZu66Q9LV 406xFlaijxrwzOLynoanGW1RtiAgFTTTatyFhRxtwcjnyoOmUrwyhaGUIcXxHEpAW5jG4gc1YHZm vdBDu/dM3w7vkNKXfumb4d3yGlAtHdMLw7XkFTKh2jumF4dryCplApSlApSlApSlApSlApSlApSl BDu/dM3w7vkNKXfumb4d3yGlBZgSm49lhrX7o7XL/QKuJbkPjfJdU3nsYaO0D61DrE/trBRXi4i3 Mn2Qhjl9QTWxUHjojH5z3897/nXnoMT/ADP5rv8Ayq6cAZPZWuaaS5dpsjVD5PBkAx7O3/dTCSf7 XH50hQ35/M2igz3QIn+Z/Nd/5VXoMT/H/Nc/5Vpf/wASen3oW+wQxcGUSER3nAtYWQVhLjqEoaWl LSASd7q0BWOrnkazUfUsm5TW02eIiRa+Jw13J57hIc2qw50RAStT2znlXVTy5E0Ga6DF/wAf81z/ AJVQwIR7UqP1uL/5VrMDW7t9U8zpu3qlFl92O5NfVwoaA0op38QBRcKsZCEA8sbinNTX9XQUSnbX DSq532OoNvQooxtUUJXvcWs7W2+uOso/IZIxQZj1fB/MP8a/+VUVDtzaStY2pHapS1AD96qi6duy r1Y4V1Ux0fpjQeDO7fgK7OthOcjn2Vgtc3ptibZrKlp2U/MkCUuJHTuccbhkOpT7kpCn+HkrITtC s0G09Bhfmf8AqV99UNvt5OS0CfmT99a5G1k7GRcvX8dEZ2C8xHbahrXJU67JbS6iOgbUlTo3jsGO eeznUm3a3s0pla5W63vMpkrkMydv0SIbvBdU440Vtgbjgdbnzx2Ggzfq+3/oU1XoEbtZyw57ltnH 7x2H9oqzLucOI7DadX9JPd4EZKesVK2KdPZ7glBJNTAedBDmvOLtNwaexx2mHAsjsUC2SFD66Vbu nsXH/FAV/TiffSgxFrT9JB/7Gv8AYVs+K1+0t/8AgVf5bflFbFigi3GC1cLfJgOqWhqU04wtbZ2r CXElBKTzwRnlWEtWi24qIxuNym3N6OhCQlx3gRtyABlMWPw29vwC92Pie2tlxTFBrsXR6YsB+1NX OWLQ4y7HYhfQgMNupKcNuhri9Td1Nyjj51jm/R8pq5RZYuT7nR4EuC2pe1PALwabZMdllLbSA2hK 88snl2+7c8UxQQ7XbIdqt0e3Qmw3FioDTSB8B/7ntNYiFo9qBYLjb4cgoul0S+qXdlIBdXIfCvpi nI9jd1U55CtjxWOlXuKw4WWm3pjyPbRFbLu35KPJIPyzUqqiO5dJhxGIcRiHHTtYjtpZaT8EIG1I /cKgxbE21f517dVxZMltqOxkf2LDQyW0n/G4oqP7PhSNqe0vP9HdK4kk9jUpBaP9eX9ay2KlNdNX abpE3aEdAXiSi3zDdPV90TImTbgtpsPfSzgEfQlZASpllPCQsg8ueKpL9E8KYqdHenuizyGWmWID Y2lKmWylDj7u7e9h1a3sHAKzlWa37FMVpWv2TTs5mYLrfZibhdktdHYU2gtMMNnG/hNlSzvcKQVr JyezkOVZ/FVqtBjbqPopx/6Fz/8AlSvV2H4vMP8A0T3+xpQR7Q3+Lwlf5LflFZnFY2zp/EYR/wAh vyCspQecUxXqlB5xTFeqUGFv77qlw7VHWWnbgspU4nkpLLY3OFPzxyFJTVriBuJHW83IQnDMWGtW /HxLedn1qWP21Iu1oM5ceSw+Y06IVFh8JCx1xhSVJPaCKhG0agUlxtE6NFDpJcdjRsOKJ7Scq7T8 e2vNXFWU7X8fT/WJuiXp2M3ZVxr2pMi4u7uhsgJW8kq5N80JTzB7VAAe7n78/bGHGLdFYd5utsto Xnn1gkA/1rHWjSUC2yOmLWuXN/TPc8H4gfH5ms5WtGiq+VW09v8AZWmPKmKYqtK7tKYpiq0oIF3H 4jNP/SPeU0r1dx+TZvhnfKaUFuz93wvsGvIKyNY6zd3wvsGvIKyNApVaUFKVWlApSlApSlApSlAp SlBCu/dc3w7vkNKXfuub4d3yGlBSzoHqyEr/ACGvIKnVDs/dULw7XkFTKBSlKBSlKBSlKBSlKBSl KBSlKCHdx+Spp/6d3yGlLv3TN8O75DSgpZ+6oXh2vIKm1Cs/dULw7XkFTaBSlKBSlKBSlKBSlKBS lKBSlKCHd+6Zvh3fIaUu/dM3w7vkNKClo7qheHa8gqZUS0d0wvDteQVMoKUqtKClKrSgpSq0oFKU oFKUoFKUoId37pm+Hd8hpS790zfDu+Q0oFo7pheHa8gqZUO0d0wvDteQVMoFKUoFKUoFKUoFKUoF KUoFKUoId37pm+Hd8hpS790zfDu+Q0oFo7pheHa8gqZUO0d0wvDteQVMoFKUoFKUoFKUoFKUoFKU oFKUoId37pm+Hd8hpS790zfDu+Q0oFo7pheHa8gqZUO0d0wvDteQVMoFKUoFKUoFKUoFKUoFKUoF KUoId37pm+Hd8hpS790zfDu+Q0oItrulsRbIiFy2ErSw2FJLiAQQgZBGalet7T+ux/5qPvpSget7 T+ux/wCaj76et7T+ux/5qPvpSget7T+ux/5qPvp63tP67H/mo++lKB63tP67H/mo++nre0/rsf8A mo++lKB63tP67H/mo++nre0/rsf+aj76UoHre0/rsf8Amo++nre0/rsf+aj76UoHre0/rsf+aj76 et7T+ux/5qPvpSgi3S6WxdsloRLYUtTDgSkOIJJKDgAZpSlB/9k= ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://view.atdmt.com/IFR/iview/mdscpefr0120000001ifr/direct/01bgexgmt,bdodfizlwAuI?click= ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://as.medscape.com/html.ng/transactionid%3D1189189926510&site%3D1&pos%3D112&affiliate%3D1&artid%3D558835&pub%3D530&pubs%3D2036&ssp%3D12&cg%3D12

------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://spe.atdmt.com/ds/AAIFRWYETEFR/EFX_20070622/EFX_20070622_728x90_v2.gif?ver=1 R0lGODlh2AJaAOZ/AK3Y7y5NbFSSy3p6eyQtNFFkdf7//yc1RXG06Nf2/kRLUry8vEN3rE+HtzNF VRYjMbjo+5rZ9hIrSTduqixXiPX+/wIDBEZXZprP/ofG7M7P0Mft+zRllmObz7LK3G6Fl+38/2d4 i5Kmt6nj+A4ZJmmm3HKavYe13Imaq5OUl8z0/tft+Im96pbL63mlzaa80OL2/oepx5YnH0Vlhlhy isLZ6GOJqVd5mnWr2REVGeT7/2QZFJu1yY3N8gkQF5i72M00Kx1Eb0JrmXqUqWiVullsfnnB60Zz nJvT7ne14I7U9ZfF4AUJDhc3X+z3/ZWtw+/v72COth9PhFuh2XaNojIMCWuizdzh5cvi8Gmx4IvR 7j1ciWGq42qQrYqxz+Hu9iQ+X4Su1ElvikZ+vn2iuTxeelaZ3F+AnZ3g+S1foECJxxIGBb3w/mJ6 pezz+oGfwT5AQR4kJTs+Sk9smQoQDx4+VhEQEBweI+fz+gwMDzZ3vT9/uCJgon2AkgAAAP///yH/ C05FVFNDQVBFMi4wAwEBAAAh+QQFkAF/ACwAAAAA2AJaAAAH/4B+goOEhYaHiImKi4yNjo+QkZKT lJWWl5iZmpucnZ6fhRaioxaCTHZ5pRY5OUw5eX6liKS0tbSxd3IEu0y2vqN5dnZ3cQQOVC9DRR54 KxAbKhswFSBOIBUVX8lFCgq6cXfh4Q8EB3UOEg8SEk0cYQIcW0JbFFIUDWV1B7sFMTEmBXYFCPKA hEEJAepIuIEFCw8FPphIzMOEjo8HKLD8uHHggUeEZcAQeHCHRA46EifmocOKGAE5Di6cAQCgRAkj STqMGdOgA5IWMd6QefKiBgxQSJMqXcq0qdOnUKNKnXrIViwLp2C58pGnVaxFv34J8iFnHwE6YX8F YxXngggRRf8uFPDgJMGGZytgwHCCDRseDyg+cDuwLw44w7vOrWMXREiUJGMoSJZi78iZAPsUUBlC BOCuIEHSeXwApjSVGjVe0CDBhGIeHz5IOPCAxQWF0evKzNhH0iTXPMBb+8jh8kDMGwCwsECAIAMC M2oahPFQw4uXJVhWrIBGtbv37+DDix9Pvrwhq7JOYX0VjMmjtLX8MDmgi4AP+LZaszwQAgU3uUXU AEICALTAAgR79YWNGzV4AJcDZe1iWDHlJMROE01swYAVJxwhWT1ScGCCGOeEQMUNnV3wWQCifQTG DEO8IOMQD7RGEWwPfIAFADc0gduLDoxUEmx0AEeHHRYRV4z/HApcIEYLG7BgBAsZOGeGGTjUgAVt X/ClAnM9mCfmmGSWaeaZaCKFniAWANeVjbJ8BRZ+osRiTDk50ElLSg9cIFhZ3cj1ghNfAIDEBjoo 2BceDYoQAoRm7VJOHQOxsw4YQjTAQgdpUMABB5IdEUUZN/g3gwlDqEhAABSItk4dZYghxhM8PCGC AzbC5sNsK3jR6kcIzZBOHKzANhFLxBUXkxhhbIBEEkb00EMSU5hRwgiE4mFABTqMYIQARkSQ5rjk lmvuueg6FR8psawFZyR6ipJLOSTESwsJF4QQUDFwwNHkXNToNU0111yTjQcePPHBBWUR5rADAwXR xKtzHNFB/wkMCPHpPBQcYYILVCgwAxldBHkAq+mkHAANZQQQgwhU8FBERFs9MMQXNZwR2kdNUBDA A+AUi5KNSpZj3AUzxFADEkpk0EMGOQlQwgaKJsACFz00F2a6XHft9ddgk3vLIHXKx8q7kuAXCwkN 32HvKPiGoOJw/MJxgVwegKDDBtrBgAdfCv7FwwtUFOCNHIg7QKkUEi+2xRFjlNAAB7FqLJkLJ8wg xxleUOEAYSiP9kAdMwQABhlk0MADCvblQMIDRWT3RhkTf9RYHUDf4boPRa6lJH1NlvFGgUw3bUQJ AnQAATZ6q8AGG8ezsFwJYVdv/fXYZ+/JKFWpgmRFqVACn/8gOTT8wNur+HnBA3Sw5BIcTN7Ng153 5ZVg4Am/IMIHBTjgv/8BkMLEVHaEIwjACqDiwAzosYUG4GAGF+iCFz7wuZNRoHaLCQCLuhCDAqDg Bap6wGy+sBEWpUwCFBAWSXSXA961ryXFOMC/TLA0FvRACT0wAgJKgIPlVSABCegWGrTABQQkgTkI 0J4Sl8jEJmovTrNoX2vcU4nx0aFhB4DPGrACtwv0oQBua5Mdiga8u4mALwlQARATADhqVMAJCePB 6uTWjQC0bDGXEsIRbuACAaThUzNYIAcaIAAxdOEJj3IAGAKwBQxJ4AATC8IFz8ADGgzBAx8YCQFQ UKjJ7ez/Uv0jADh8wztWFA0mcnEBEgqkBSREgAUlMAMLEkANFegABCqAwAgEwAcELIc5TgymMIdJ THS1yTVUrGJY5PMSwqQiLfIRRZ8GcAG3xUI/ZIzfBYaAhx9GQxrW6IsBnFCDJ9BqdXG5QMswxM4X iaEANsABA/4ohAVSIA0CcMFQQqBBiM2gcZCUABh8dgPCnSEZBCBBAa6wgihwYGfqaEIZAiLKkrRw ODB8CcTKQAUAYCAJLECCSHc4NQOAAA0Q0IEOIsAGNJiBD7KM1taKSdOa2vSmUcEKMjEBnzgQRg52 uEovfsEEAhSgCHLwwVVE0ZoxFkebIciLMyCQAL20ERsr/3gBURLGvzJQADQYWqQCCyAGIiDwj5/i QBoYcAIPeOEMFwhATP45QAwFoHRleAIKyhCDJ5zjBV+IQT1qF9HSjWSUpkxWDGNShi7UAABO6wES pCU9H+bym2iQVixLwIIWjGADOA2taEdL2klgJSXJvERY7jCSA9xhqb/wwQEKoCL3DPW02CyOv+RC Aw98wRkbYAOCFFUBRv1gCUvQ3xm2wLiJNSEIMzhCEQpwBBb48VMF/FQDWrAEG9xNnWKQWBMOwA4K zCEhQ3jCBWJ2gyd8wQMz+Oo6PNKEu+pjhYkNx2KRRgSaTFakGNhhEpZn0uDqMgIjiMC0TsCC5Kyg AqWNsP+EJzxa3EpkE77wQw5EeYA4pMUVcjBcjWBLCqIVbbdHZcYKAKAEql61AgZgEBKWgLAfmOCh eJSCEIpQBDFYgQV7+CMDGiAECkzACi0wwQwmOoMbfHW8kRQCZj7wgh7zwLdYoAEjwbCYA7wIM0IK R0uKE7wu0KQFEXAlBmCJAwDA2KQJ7gEaFLwBvsEgL3j4whcozOc++3mJp+UiJ6ySB00S4La2YNsF FBBGRJe4qRn1lwKOClgYBFcFK3jxG3eEsMcegZ0Ygi6Po5uBEqRhAgw4whyEsFYW/MAGNCDrcjHk 5SC8KB8h8IDcfpBnEwRADCZ8ZB1SyOWKioMYS2KsCfz/i4Q5P016VNsWt3rAhqZFoAU+xAY5qfCE P3v72+A+FxcFPWh2yWdCcsjTuEcBYgUcQN3wsZFTyXEAFPOAL5YegS2Jmw3UoCYKoBGvjnkshhkQ oQVjODUHbiCECXDACkvwQhduIAYbCAE0dXguBW4wgzosgwoXoAsAKCAPPEqgDhxXiLH1uwtUlsEE ECBeBBCsQwzAwADS1lsPnhGBZ0zDCVmlwQV6G+6iG/3o41k3FDVhC9beocO1kEguFGAfpuJnInZ4 Hb13ewEU4AEEG/gsGw2GjW3hAQtaso3p2LkyGsjqDEtIwgTWmuoJTEA6EfdCFKJwBIxjSApROAMY CqDV/yGsAA8/6NgF8RiALoChDhKaUAxlqE4ThN2Grpx5D0Zw85xHIwIlyAAAOv8FEQhdLkOoAdJX z/rWL0Ui3NveLWTr00OzywK5cEAcbutoogqHBO9D8RPwYOk658Vg28K5ExrSAimH9blzuAENinAG DyDBjxM4AgO2P4EosAC5P3CBEBgHBtBI4QY2sGNRDo+FE0ShAaE5+cSEcAZ9FIZC5Yjfy7EQpR5E AIdVMnowhg30MwIjwAJtNg14kCoFYDgXwAMa4HoSOIEUaFpD1QugcAtFtQvvpgqiUD4KUCPcEy8S gSzhkH9NEgI1gG/1AwPI92YVsAI1cAOmE3BScAQ2cP8GRfABHgBZDMABQjBkDfCD/dUC3MUAX2V+ UsAAoxIAL4AHf3EdtjFAdVAHQTAqFSQpHOgA/+JYhnJDOHQ8WQABIIBz2xJzKjACKLUBfPEFVDBd ixZiDlKBdFiHdkg2F6gmteBTDwB1V5ED/mJ76MNuweBULecAHrSCIAADKqBGbKQgOFcBMGACoDEQ A3EPOph6S5ABAmB3Qsh9bWaEDSAZzEUZjjEDYlADFZBlnAN/EmMcAcABAuA/hMGB9BETcvEEWIAE IaVgRjAl4TINZugES1ACaLCGZegEyhAXiCMHVOABRXCH0jiNrLduSXELhWY0Q0UHBEB1vYc+TWWI 5XD/AUXAA9lhDXW2AbRUdpEoiUSgQTV4g2cQAiKABV5gBVYwhNvXAPw4BnvgWZyIap/iKRNABFGw BH/jAXtEBEn4XIxEZHL1OXIAP9okBkuwYtIzc84BLRDAF+1IICyQBVkQbU5QOLTlDcbwFnJAjSzZ kt42NhlYJ6pQe3JQL0UFBwQACyQ2iOF4YtuEGl+gN9pRVddghmUHAi5giQHEADZAZVgQAzZwAvm4 j+/njyWAYNDBAfbAAXbXAEjgN2h3AkRAgwPRBJTRACbQMhGJOIFyVBcJWUgQWTl0lR6JcyAAAgn2 Sl85Tihwkv2iC+UYAg/gkoRZmKQFkzHJJqVgBy13/2hscxY7OYhMtRJOFQf+0lta4oLVoB3hZJR9 UQNbAAZSsFY2cEk1MARn4AI4oI+EJAD82ABJwAYIMAGTESIMIABsCABv8FgdwAEaFASMwwE4kJbf 1Q3/QioesAEAYEPSEgE4kQEpVYaRqAMw4HPCqIx+aRYOgAJPgCuG+Z3gWUyI+QnrUnsdsQvwJpn5 sRLuM4480CB5YQ2L+AUuKE7JZwAwAHDAaQNegBpD8AEmsAQNsAcMMAYCcKD82AFYaQ+SMQEdcALa 4QJt8AIAMIo+Yw9S0ACvNgO09V0NWAZRAAAQYCDSogSZlQVWAADW4Jk6wAYwQJ0D2JeGUx93ADsv 8P8B9RKeOrqjT2Ru1ziCa7MP9HEA9YIVkameNsISMYQMRfEFzcAXToAHKpUoMGiXSKBBQsACKwAY m7EEU/CaBxqmAjAFm9eb3AebzxAGRPADJ0CbICIPLhADN8BjDdiAsuICEAABVSIt/hcBvoQgTmCU 26E3QPRgFSACDegNHUYsByACD1E2PBqpkso140mebCInsrUL3qie8aYfrPUABWBOL7ACX6ARqiiJ akSlimIAeHADUpAEW4oCKTAEXmAE0dGaYnox0NkCyWMTRjACEDBjS9CJDrcF8qChbzCPIVAEIUAD NBCVdfaLT1OiOYQtbxaJCYBgedp5L5CoEaI7d1D/BFVGAuEzqeZ6rmhSqZYKW+e2DzXJqXQidQl1 AFTwBrupZz+gOm6wiCsQRGQnThXQAiUQc2+BAl4QAa4JphdzoCWQBRmwAUmwB2qAAGhggHG5KXvg cBwwZD4RA2fwAR9wBmfQBWGABBCgYNSaAUZQJS3wYGa4LdVZZxGwAWV4BfpyAXCwDywkByJAI6sQ VOgatEJLHuoqeyMoCo9JAGEErx/mCsRyBwWwGT+ABe8Va1SABZIIDSr1rwPIBhGQGiJgTnqqsBdT AlMwBUWEYFqQBb/qPDNnq3swBj/IAB3QAgDgAqjSGUtAExGgBdHyEy2gsjiBBC77stwiolS6LU9g /zg5K0omQQB9IAJyMFRAO7SWe7k5xW5LR563Nwq5IAce8Y1MWwvE0Qr88QFv4AEyKDcpRoBr9K8G AwKMolU/UGf5GKZla7ZmwAUtxgaOmAC6NAJre6AdwI9GoEss4AIl+wwjkARPkwGrFLhQg2SB+rKR CANABABUkw0ioAD9orS6o1AicAGIhrnme75KUWKba7SykB5xgDjoObrLZAEsYQcWoFAhO7U18AH/ 4kHdpANAdD/Mc5dYhTB5gbDE2wEXgwA4EEtcYARaoG9pxAYjYKIjkAFTkAU5FAHREHNYoEs5FFkt EJcnAC1Z0AKd55nYALxsOE4rcAVU8L1BQxYo0P8HJLBU6JvDOsx0VqGHZSOTJGCLIyG68vuBObAG azAfNHADJkAbKOA/k1YANIC13uSvBEwNBgN0fwMBOJA8CrzAO8QFaPuLSjACvptLwNpSWgABz5NG 0QBZVSLCcZkEbCt60mm4NGufFeABV3AFRVAYunMRIZACWVS0O3zIiDwLnfujQGoBjPkAPtBMVVfE +dFCcANP/JkaBVBvUSyuBZNG/toXd1mUMMurX2wTOIAAWVBEGRABQxTBeWqAvkudQZQALdU0GYDL PWCEVaJDIjkC14rHNFuUFUAUX9CdOvsKCoUCCtB7ifzM0Hwe5hZ77Bt7uEcAefK++8AalBx1rzD/ bnIQskSAMFSwD7vFY9xkUqB8SwQ8ygNYASpwuzbBQ0eEANESwZmlBVVioiilRs5TwdICvbssUpMl JSqLAD2gLdabfD8EOHgAMxqgASFwWHdgEQrgHzZpyNG80eZrdRiomDH5w6JAB4YhCnbQuJDczbTA Er2AgTkQtVHpATygKvV2VAWQazDmBNBgxbF7xTCABB0gNTiQBERtz7+4sv+Xy2igBAhmgAaIAT0A 1TdE0GHIHETtZgsNs9PwZk6AAiHwBDUgueBwB8Nx0QOwe1x0Wxy91jrMVCkRJ+SGYWGxYeqWB8ZB GEWq0mbTCrRAr0TgAj9AOOfJJJ38A4G6N+p4/0sD7M4EiAQNS9RKrQRaoAVKINmTzdTHOGczh0MY 8H9MndQ4UQIdwAIpbL3almk4t4BFcEnQWFEtdNF9cGiolRI6yda2fbkWtnQfzcOrlZOjEAfu1hEe 2M15QNazVwQmYAJe8APjW6OI4y91ejOu+6Kj3NNl90N1pgKMCAGa3bdVogWu3DTg7dmYPXNDBDU8 FAZYm9WRSMoGcAWC8dVh/Q2scNGEXIIRMTSwcdv8LbRpvduDAHu83cOFhtYfCL+QfKSc6grfTGIH 8DEuYK9UALociDhyUQDVB2N7k6rsXN1XrCAJYIBLbdn8POKbXdkIlmZzDFJLsILsLW3WWwNvaP9J CBMQBUECCiACKJBUutLjutLfQC6pbi3g5wHg4jM+jBlGV2EM+3AfKt0V9isKWwQ3nPPXqBIC7/Y+ cgAgNBAD/9uIHD6ld3lLWwvAaWjiStBsarjUKCW8WiBZvBhSEHB4wczebmSGGtAHy9oHL4BJHeER BaDj6dbjxeI6BhHkiB6eFjZUVVGuyoQfrJWeqwATHYg+kYmBDD7cJeYAImCvIFM4kHyCnHxUlgQA 10CdqUrdeqNS2AtE/zxnae7Ka97Pt6QCS3ACNIYFdfniRmm9bsADfdAHO/gEgEF15BDozAwbrGAQ zN7sif7shTnbkBoKFPHo0IQVxeDk6SFDoEv/xL4HRYLmCnfwTL7wAFTwD1ZABSC7Pj7Acud8BjfQ AFSziACMvaze6m7sPNw9c07t1BCg3cRc57xulO59zFSg51/tIDRdjt1bEs3eG+NADtA+8SyJWtNO 7an1HvaygeVrAQ+gAJ9D7vECWwLutFFOVBfwD1HwTh8gN2QNfPySgmdgAw2QAdeQ72vk6h2cp9xd sf2epy56xwM/9NuCBT1LBSHwAVfGA5tsHEqPAj8zGlrnEZJSi1IRBwMAB9ZTAAPQ9V7f9VqfPXAw AAVQCF5/CFx/1otA9paQ9l2vAHFgHlgf9pbw9VlfuX7A9Z8w98X01j9sCBWR8Y2APoW2tNyT/wNN 4gCSLpningP2q+ClEAcf4ALeFRNJz+6/s1s08AY31gAqMCBgHg2+K1w83+8GyPN5+vkCT/S9rnwJ gwL/qfQ1IDP+E7VP4DnzpQ4OU4sjwexSAQcGMADWswDsLfzYkwLvnQKFYIZ0PwhQgHPNfwgGsACW QPzWa/zjAfzYXwkLDQUKMAjE/wna3/cUsS5kEwzrmwiSmQPv1ntksWgi+DZsEgzI9s3jkwcXYJAF oA4FAAgfIRd3Pjl3cQRwCgU0XXMcAjAVOhBsG2wQmpkQI2gjnSOgmhAbOhUGqaqrrKsVqKoVKy9P IkMfVDw1PGIBBVS1Nw4SEgd1YAEBdRIPD/8kzyQ+Pn7U1dbX2Nna2XAGA9vg4eEFBOLm5wYL5+d2 3+vv1u3wUFfZBlcGKdcKBhoGcPACLjBQjYA/BQETKlxILV01BVCgxGForps7ihgzBsyTx4LHjyAt +GFipyNIax+phVzJ8qSFRD5YMjlwwcGBmC1Z+rFA8lCiOHdM5gy55sCNKCHq+JBwIcSHCwRy+CQg 50KRNjYaEMEBgZIKNqJIhQo7aoNZNglAwGrFtq0BECuw1Hhha8gLDzxozDgT4wmVGXWOIVP2gBk0 aNKmaXxncbG5Af8ch3O4eKDkbJbfUb6WTkM9aynyRb5sLTO1OPlIq4a32U8BAwVWU2ssuzb/wzxM hnrMkyO37pY7d/7meYCA75UPah7IMfxjHkQECMSJ07v5RyZMSAT4YGMGCSYEmoYg54NEIjkKrNpw 0UHAFDaUwIqKEOFTJ/ojzGLaoCItCLcAqgLCBjVgYSAWHvwQwxI/2CCGGDecIQYYYCxzgGGIlRdN YtLYxo032ihSDjZ2wDGiNSaGAxlAKMJhRzaJWKNINXCwuE1rp51Yoo0tvliNaQXZWCOJQ3LDI5DX xFFkNTg2tABkE1VzxZOjzeYiOEryKGOUPxJkzZTX1OjjNTNyM6YiXAaZph87BtSmNq2hdlGSKYYJ x5rUlFiNkiWCuGed2FzpoYfY6cZEDnYc/2eodSyRcCdwOSigABgPXCeTSEzcURx1PijKaKEPhGBC G3J4FF4RNJRxAAk5RFdVAWd4gcMUXKAxCQgqjEBfBEooQR8SSORnliX96fDfWgHG4sQGAADQAgsZ LMGCFVEcQYEUUgQABjHENONMhhzSIS4dTHTIkAbUoOuHuuHQFs9AqSzgI2QDQBFvNXb4kw6SDa3y TQH2pqKPk6Gps28qUBSAjwFQnIjNZukUTE1oCMdGDcCq6NPNKt0sAG/CCzdcDcUMW9xNCvpeoSQr WpJ8RTmQqaKONekQ4KcfNhew4sUBp+bkyKq8PFs+/szpB5ILQFENxgIz6XEqKlNDr70AEf+wcDo+ Wp0x0AiXYxFqM1NzhbokJ2xP2D8f7aUd8PaT9dUDq/2alySH5g7bQY84dZWDyobd34X+zRMdOeAG +OGIC84oT1Qxp1MeDihn0nHC8cS4idUtHpJJeRRgQhRFOJ5cAUUUccAddxBwACNFvNFCEghEkMAr CaBhO689ZJCBFsGKBUF/MKj1SrIGyNKCC9Q20IANR3Awwxxl1NFEE9x2e9gz0oDLYWIk9I3izV0C 1LHU/Uw0EEJ+hAZQzNzYfafN8qY/GsMLKABQKuunArPPZzMJRf35+0a+oOAjKGjADngjQIn8ISb8 +SFm+xsYvdikAQL6oRtQyF8KFvgPQZH/7xtxuILSVqYBQP0MTORrx2gMiMCBjIgyEwyh0i7IsBSY UG3XyAz8XqS+fn1jfA+8xwDu5Ad6TOQ17khaOUITm5PhjB40/IY/9pSaCQ5wTE7jzMwyA5nYvGZg RgxiEvtRAIR0zA4h9NNAqvY/8l1hiHjynmT+xhHDHU4qiUucHfP4mxzIwTg5YUJVFOAAxwWSAAoA pOY2R4ePHKALJgjBATzChOSUrggKaMYBqlKELgBAd1o4BSVGoITc5U53PWhBBIalCf4E7xWwbEsF EgCAMETBCg0QAgMokAxtBSYw3PLWtw6TA+4lplwaKswBDkARdTmzIuBLGw6DaDI/bQYf/9rYWRCj JKeGWLAh7IIY2rTovzEt4DOuiQwBFlDNMTIpnGGjzDmXFhknpo1fR5thEFnUJD84JDQ+0gC6drbO dt5TnzsDIjaQ5iUoncaa6OTizbphMT+gsB+nGWIQ0aezKO6TfOWY58X4Js17emkg82rizdqoNhtB Rm/WjFtoPihHD1ESO3XMqQ/u8J2/jeunQKVDTsnFBKIijifY8cEmmeOp64QnPXEISeU8EodENpVR OyGJSfzggzm84SlM9cEDFFAEpxSgOOgpwgc8AIBPCG+WI9CCEeZK1x6MohObSICxYDk8VxgABjhg QAM4cIQGUIADFACDAypUPW9dLxrYy//e9R6wzMo6oA7MrKm7qGGzi7z0ox7tbJesVKOJaBNIlGmN OLMIp3iijaUe/dMEp+lP17IWto1xlzy9dA3cWnOcP+NHbOwAIm2eBg6zpYxvfxjN0ZbmpLytrTQ/ a1zjZmYgG/zeFXjUGNEe7TPLfdg4d0u+BaTJujMEkmm6e7OdGbemq/HN4QyXB0NI5b7bs+99peID BNJBGuLyQR3HZUc6UMU4exQcdsbqAHJYzlI7uYMc4LDVRYrEAnlI1HUcYIIhFME4f7sDI85wBhoo AD0F+MAPAJAfEOggLTrIFQuSkAQj6K4FzQKFKECBFlHGMhaTGEEHckkBCmyBAkEIQmD/LtQtxz5W Q+UpDDEOQCEKXUiY3TtXurYsjs3G9qPazO3NMuMv0A7EY0+bmWptW1JylpR+HisaNRRwNTXydrVp g/MC5KzbLUaXtbHtp3L18RrTjobOZZauoj3qZec698xoTm3Y3FslyGgAzfbKkz+gMIAxzW0BLKLN RQemZzm7mbWmoVgKomRd6D6XRiDqxpQ8ho/8aQm+lwncUf9mXxIg4gE8fewz9kvsYhrCDkKVRn3j IIdVMSGn0MYOIht8AF13JDd+lENvCqU5+SIqN6A6Awqe8p3EMHsvVPhAES5wARUjIQL9+UQCIBCB DGQhCzROAgtaAKwIiAIN/v5dAl7Z/9dXwGASSCACAxDbS+pVr8nNQAwJmvFwxYKhsgTA8mHg62V3 UTrUsR6zl2pUWjN7YwAoH4DF1gzofkpTtW9MuUZRowGv2bnlbBaizMV3M/KKF9buEPQWlSbSndHc 5kFXc9jEbDRHp0tdA5G5yqcbmermQ+rWUJjb9kQxlboDoPxAn85TfuvWEHdgQILDQETWamqol7di fpLMDX1rXDsmj7pOqjRyIMxmRMfJEwf2HaTi68Gjbr9ibfYDjF24xCDbB+QKT4PlAPk8CJUjFlCq HO6A02fjHe8cefYdSvJs3PigAE8YAg1WpV8CBEAMZxjCuDu5hHdDAA1Z0MIIMkDjEv+UAAe/13cL +O1vgH9CWCpQSyoqsAFZBA8JUdglL3358CY/Q5MBKEMZHOCAAFwAQgGQQMYB/9hmcpld4PCyd4O4 P5CDkH/4NHlracbmRf+8pLC1BmTQRxvT4FnR+Qd0qPZn1BBe9sdar0EAUCBBVWcA/PdbBbh0Idd0 bhddxOVn80c+tlYN70UioRE3s2EvK+MOYZcC+hSA/fMQN3cNkFEP6FWBrzY037B++kdSducYCfZ5 HHJ911dZGOctcfAAQIEIQ4g6E3cADpBI0HBfw4Z4NBEAmMR4/2UI6BEVyPRfl5dh4gJtA5aFUkEd 42IHvXEAIhAD3XE6REhZAUADH4D/AiJABi6wBPWhBHOVAUYwBb6Xh76XBLqTAfwGLFqgBFrgb/1x LCCQABsAAhAQPCdABEcQBEXGWBLgcJM4iccQANznfZiIWcSwhmLgAM7wLYhnbIohR422GRLlfgXI LpmWDdrkUH7AD0lHfzh3I/X3XUCzgWIEgy/HZiIlPzx3ET6XQ7ylTUKXJ/1gADCli8mFgRr4ZcQI Gn4Ci7LoTc5lXBSFjOrQZ7S1IrqVAlcQN7/YQ6eWQLyIigTBjbTFfjTlT3EzRaB1g7n2eciETNwz cZDlLarjgxcXHcWhj94SOQpwAH03Hc2AOkb4AJEDhRcgivclBwXgAINXbMWWXxzC/4QRt1+D9wBn 8AMmcAZn9QD+iIQX0AYmEIcAYBZoQFdZMAUC0AEwGZMlwIfD1wIZwAJ1uDtGoAVmAQMbkAFI0HyL CAJJ0AFHIAWIBQZNkH3J8DxHcATdYWXL9Hd9dwAFcFbFxCrFtIU/xXHpIHOxsUY0xICqKD9DRDHZ lA/vgzX5ooxvVn8ut2itMUEKOEPjEwf2MkZDdIG1uIt1KYMDuJc1CEJXgE7HWIHolFAOgZcQuIsh 9BmNVoEohzJbhzNs6Q8vFHIz815hZDdsEkYTFEMV9GXn5IAcCCJ/+TAxB47wB13iw1KgCRu8yFls iQ9jBBCvsZk2KI8ZQYrScDgWCf9ZwhZ4zCBldcB9irVYTFYH3jeQ0fGc0PmcQSiSF6B9NNCQ3oI6 CjAeBFB4CPmdh0dMUgGeqCOS40eEQPEAZfADXkAEVFAAzYaE6HEBMxAFLaBjpGQECJAFXMAFAvCS MdkBVoADSXACLHCgM1ZjdmgEfLhvCdoDh6hXPVACDDAGHcAAR3AGUVBiYjADRHACYRADN7AM4td3 10MTDZkYlldHgOOVrKAOcaAv5fOMsWUHobGA8Yc3shkzqSCMaPN/cfl/FYgwNkIxnOYzWtMwQBo2 bZNBgJk2SeowakOkgEaL5BM32mSkkEFqTKoKTgqNz4UwT4JFPNpzAgU1y4giPRP/NkyDNWzSpGZ0 M3ODRU1ad6swJRU1TVqTCjUXgjLjdPJTQ34So6qgAay2m7xJEYexPfhlCNc3TDwoWY4lZcTQBIOR DGUgBtdpEz44lc9ZHM/pAKWzF4mUcdFxAVQQAg5gqtAZhOMnhNMRq7I6q0gIqtFJAGBgA0vgAkPg YZmYHkVgAyfgCVqwnwiwn/w5BVbQHkRgBc7qrDhwAkmAA8BXAllwrPeWBdXKh0iQASrwYgmgO0bQ A0YQrRfKSw5QBl0QBl4QA28wA//IU4eHX4SDSDfBRx6RqGRyQ+cQf9mwI1jkPVmCDYoQsAsxsBiB sJJRsKfmBwqbEQBLi2XSLkRk/ycBqyRSag4PyxBoEigViyUeJCP8qq+SoV+POkx9B6k8CA1OhrLM IAEUEgQBMAPatwVCcARCIAQccGTJ4AByIAc+u0xN0QhnwKmRUwQo0AcDiXH7+KkjeasYZ1mc2qmV VQZvwAO9+gZnMAM3YAX71ocI0J/9+Xsl0B4w+Z8xaQW/R6DAR61ZYGMzZmM9MLdK8AnJpwMwAABI oCA20AVkQAOYCLQkpq7tOgSgKIQ8lRhYSC4GZlVIxW0pQbIJgVJio0+Se7mYa4vwFZeZ27me6xgA RjiER1nF8YMah7Lm+aiPVRjUY6nTk2SHxQETwAEMULtncAMPoqkQcgYm2QU0QP8DZ2ADHyAINSGV VHu8yOuD6cF9zJuJmNoFPxC9JzC9SyCux4oAvnetJWAG7fGfAtAA36s84Ju2vkeg+iauGeBvnkAf SjACarECSxADJvABbIgCpiO0IRB+AWACT/AENEAAhsBTxXRU2UYCQ/G5j9EPA4BdCNzA+hoHH7i5 wOXAFFzB5rCilpcYlBUH1/epzMuJL1sMEnCyEfeo1UOJkxgARdZLYEABfMAHE6AHatAAalDDUzAF LpDDOWwCufSUN0ADV1kA7DbEkkJIC9m83Ccp1VkGwPu7NHADw6uhAhAFUYAD0PI6HVC2AQqgN+yS DTAGYyC+Yqw83uu9WUytOID/ADaGBPaxY/WhV0gQBmTQBSFQOlRgOqpTBAUQigVABm9YBp0iYFJB Lo/rERJ2EzlhwdpQAGiWp4r8yLWxTtlVUwsAgpB8yY/MhYYQHcVEeIG3TM5bZSRKcaH4LdVXiRRn qVWmlJOYZJBYZLBMu2A8ARPQAO3RAFEgoNIKk+aboMAnAEQgoMsKoMI8vWEwvTiAPC6QzMtMrd37 n2YQzf+pPGAcxmOwB3swBrW7zdu8B19MxmUsoAHKh/WxY6DAH2kBACZABoJwlep2IVbBemJFAyKA tdWGVITTSCshYYq0Epj8zwAd0AI90AFNR57XKnEgLsTGssWAhL6EDNtifSQg/8LdUqkXVxi/hFnS cwDTMz0BEARgILOwe1hSEARI2TwcQFju8Z9q4B4lcL0IYAYujb3ZqofA98xlPM3/qc1gDL7iu820 zM21ewQY+pRPyQDYLL5mjNMvPa6+ggaWQCzfugI/0AWpKsSlExjrxiqhRwDA4AUhUCm+kWFCka/g oW3AQdBqvdZs3dZuXRuP+zckQABBEYZMeBgURwyK1Uu9JLMB0ATfUhjJsC1Spsquq5TTQyGW6spN AIkc8NdNkC0BkC1GlrM4uwVbQFhEHX1EXVjKQ8VRQM1fzAATUKGkTcsTcNQYus03W7sNQNS1W9qx Tcs6a9mqXbs9Db7hO77Wev+s4xoBlsAGnMAGOrAC7FzHVpG/ZWA6iEJ6eSAHQxADZFAAOEFJJbES ebBM1X0Sb93d3v3d4A3eK5EpVphTCHTXk0Vxy1QHF3ADNkAENnBkZdDXDse6jR0E0zOJIZ1krwvS rjwHc/DRKgzLyXAtUoDZsGxkRI3ZmC0EmA3gbTAHDw7gczADFo7ZFp6ztY2zHN4GyhPUpD3baTAB OpvSHHCzsF2h1QzGuA3NU6DGTn3OX0EsOoAFqarHBRACZzAIi4dAa7AGmWe1T4ACpbI5Ze0RftTP kRveTN7kTv7kCDzeMPG4HMGVCr1fk0UA6boFvbQFc/De3eHf933f3OLfiL3/lFswA1x+BFGAZFJw WDmLWNhSZEdmZIdls0Kg5nRe2QCO2W1wAw5e5wwe5yY+uyZ+2hMw4qStB6QNxsTcAdWi2bCdzSqO zSo+Bu6RBRmgK77CY5eACQNXA+omxG34AXIAbD4O5BbAkTzAAx9QKSmBYR0xVcx2B0i15FCe67q+ 67y+GivhA9IhX3r0U2I4hXONhDZRnJWaffNdBkLg3iZABM06WCS9yiEdAFwus1sgBY095xSQBmng wjtLARc+fXaOLUhZZCe+cIc1BhMw5+BOu6RdZDGM2hNwzTGsBj09BnqwB3ogAGbQ0jM5ZA2w2txc 2rLNzY5OKwgACsYnCmzQ/x8qoALBUwNAnGKuTpCD5+PX5gBX+wQXkBtThXkgQQfLBG643usqv/Is 3/LacGE7AewGPN55hBv1lTpTuXh47S3EcAwzYALteQZdMPTwfQPerNQC4O4zXNoN4AJJsKy+Z7Yl MAU1rAZ6cPUtrQd8IMMtPQXJygXRLM0CwAVGUErk2p9GECwZMJMZYDvz4Ye7N5M2FgFnLwBlS9q6 BNSnPduovfBckAXA3QlQLdX9oVcgUANn8AEiYAtQMR3NjXmn5wUvQAUEQPOG8xEkIAdRxd0u3/me //lOnq8q0So5oBJDATg79ZyDp7iiu/MPUAchMAQFoNHOu7s2cAZNHwYucP8CLtAA0G4C7voGMRAD OXzM0wqt03uTA1p70sJvLTC9BsoCLnCS0D+90+8CK+YBun8CS6C3AAABAADcKuA7wa0rRpAFAsAA tg3iCG/vMezomj4CuVIKmSDcEV/478sDIoALfQAIDgQEd3d2eXlMFgRRXk8FihaSkxZMeT6JTHFy Pn6TfqChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vaQWnpI5BHSglMeSTEw5d4N3OT7K0oh5 dHZ2Odk5cRchFwQPD4MEBwcO5+UOIVRUQwXnDgHnARcB9GVlBfr6NCE0NEUCAizyjyDBEB9oFLjA sGHDfTP+3Thjo0sUEy7/WETQksXIFDNZuBjREkHFiCRZGhzhwODIBAYTYsZMI7OmHgER2MDYqYMN BBVs2KhIAIOoDhB4HoVAEULOoDjZDq3xsSXGCxQEkE2y5MMHM6dMgvkaS7as2bNo06pdy7atW1ST huUJJoluJSZeCz1LdEyaMmp26OQgcaCAHL13xJErN06CgzZtQoRwUK6y5cvl5GjWfECzAwWgHepj 6EBO6c2mQSt4WETMjRsNolix0qHEmDQMKLBc2cAKEhVoPO652eDlEZhpkqfhkFymAC5KNoCoAAIE DBUbfAodutNJhaQ0UIh4d4BAnGfXmBCgwoPHDB+T1iBTJpgAnDh5gL3d/8+/v///AAYo4IClABMX ATnYJcklzBQCDV/GaHWXJYn4QAJoz2RDwh1xmBdOHHE8IMEFbdwQQgHjpKgiOYOU12I6F+yzkEOU YZaZaeesxpAYYhxxRBQdEMEAcrpRYKSRHHBQwggjGMGFAAJMIcAERwgxk3LNTTCGAFlooRMIGyCx AQzWbZCAT2bCoIMT3jnxwxkioECeeVDlUE0BT7zQxQPxSbhgMwfcERaBhBZq6KGIJqpoWZPkcZ6B lQimjZ2RjKKfn349cMEBdOCV1x0kkDApCQ8U0MY/geoF4qqssipOOHLEuJAC6DC2YoqV4RjPBWXM IMSPKjHAAQVBSEGBPf/2BMGBEFIwYMRGXJgRpQBD1pQcBcpp+ZwWQ0GwxBI/tCCdmipAYGYCOqw5 XQU1DPEEChcoAMdTz9BxQAwexHCAn1oN49SiAAcs8MAEF5xWXaFYwGGnk1L6ySrzJUOAAoIyQYdX 2fhAx8Yb+/AAQQo9gPFgoCKGWKgPkOqAPgoc8EAhoZoM4ocgjpNZPPZsscUZbeQmBbNN1FEHGMgG EAQFY8Q0hRYQ9MBFFlN0kDRMSaZBgRRYjyEtdBBAgEQHUfzwwwk/AAADdWaqkO501VVQARZPPEFF AQrIUR6IwwzhwQ8XKMPvXZJYSIDBhBdu+OGIG5zMMOflcEgk+hnDysP/yZSTn8UXU6P5xQcA9I7G HG98TcMadnVhEQogSPrqMtsMxusB6DzDEcQ2UWwTQdchAdFGY03BS2okMULTRpRA7UsTMGck1hOU UIIRXUcwxZBCRBGDF16csMQKIBCVwPdHres2Hh7wMEQR8TpFyAMheOABDTlY4tf8fSmT+P3456// /r0kU402ICpGwiL3MFUgLHAHiMOCMjGh+clBIReIg/w0R0HNReMOCjAMNDAHuo51pSvZQEzNyjG0 AMxgC0EoQwBwZzswSOCFMEwWB1bCACDhQFwq6IEZ1CATDmzBSFZLwxhKkAEINEkNeniJbm5AhDCc QHsbOIoOVDAUorjN/20GeJv5TpS+QRTgBTXASqhWp41ozI9/aEyjGte4P0tYgw6IUAQdQDQXT4gC Ya+oyzBykIy/+UABJ3IAfBSRifn9RRFMwGABDlDIaVBIc9jQUCE6tBgwbGEOZWiCBALgwhcKTQJ1 0OQLg/CrM0QhCkQgggtOIC4d9EAAY9ADTITww99NIA0dyEAEIoADJA7nlsljCUZcsIQogkAHCaDi 2a5YgSx+wQNMKcKs5PDFGvDAAeEomYMm2aE4kKArG2OjOMdJznISqhp8MRAo7DAIAV6KFpJohhn/ ZgESdGORiPwbKNQTLwn2sY9+saBXNhSOFoGhV1vQ3QtFCUNQBmELPv86gg3OcIQZzIBHpiQCCzbw yjF4lAG0NJIQcMMCFuDgiVNAIjAnIIViaelHUUgCG6gzlLYx0wBZvIIIQhCQeBWAB1jwAIpephdR hYpUKjqPOZfK1KY6tX94VKcFhkEMsdjCAiDyG79AQYLRkIAViYTDBQ5Dz/kxCGXgkMABiqZJTYro heEAZezm0AaK3KBoDCEIbFjQAmrBZAJCuJpIXRCGIzAxBmEoQXGY01JjYUsKHDhaAyJQnfBRR3w4 NYATakAFaerjCViowQdc9JQQgagQBbXMU1fL2ta6NhV1+YQP2hm5WQBDPXzUygDx0rmFEEBjiPhg w5oRq03lh54TAiH/ycSxO3y8TndvfWsTkMUrFRKNBmIAg9DOISsxCCGXUwrmsLAmhBO4QAj4KAMN TBAGF0ShAWkwVpKWRwHbGakDOrhsZZnZTGfyoA/SjAEW4DZWztjqVot5rYIXzOByUkJyUzVPHW0x DPgU0A+J7MwFivCBD0iTCh4OiIg9OyvQUEZQlIBc/f4y0A11aHc/DAIM48q7S85AhZxkTGE2tRg5 6KhXq0ya8oyFNRcA4Az2+EwGP0CGN5iACMWxGtYae7UgBCEKG3DbMW2KxcxW4AsvoAIZsPBM9KkG NKjZzGUazOY2uzlxD44t4wYFi4dl9cF+sAMcloKCPvQBIR/o1Yn2/+EQ1QgiZdFAbjLogzFSMTd2 K2woDMEwgznMwB4slMAgHnCAC2BTMZ0JzQxOYAWZCGG8QWAAEpZgAjFQRg5wMEcBqPAGF7jACg2Y r2OLVWUKAMBtUmTbdHDa3y9jYQV4aBdPCe2QhoAGWW+OtrSnDTB1euIOB8htbScHijyYBxkEWEoK QpA6bxKgIYzMwyEqqFUF/U0aFxtMOEQ03TJ0EoYsPJoK60DaB5yWBBM7DIfEoRnQHIEFZhiSj5jD hwmAywZD6KwD+D20MpxhCDawgQmebIL30s6xU5ZCCfJLHTJZ54rD9jIesGACi/7DH/4owo3pYQ8w HEAC1M65znfun/8HezsrdsyjJDqUoE/EIQXwws+lSBAPB3zVgIpetMVaTONjKfStErDdFi6tu9Lq RRsPEEQIxdEZ0xwhCVI7ghhmcLUJsAACMbhBAYrgD3xYtADyiBENzmACL/wAyhQ5QhmQVCwBZLkC CajOuo7SzP5m0QkrqIEX7so77ZYDrhI4Ks83z/nOjyW21ybAhFsR22Zoe0EhEMG+IFWJByhAHhaO elndONB5O0aFDaU30az7QnAQVVSOu1jYESQYsnfGAUcogRnGwIEbY60EAAgD9mjwkDN8oAB1SBlh AlCAM8TgB1GYXRe6MNGM30BYHFiCli9bAZPzF4sVcAIeVvCCM+D/HtGeikYnPM///vvfFQfkB7OV ILGgMAnEehYgByJwAQhYCRNDGZ0QW7KnFRQiKQSlVrwDQySQddNlUQHQb6ACfMClDBNDDHnADItx DjcgNVYzXhywakdgAjHAFBfAb9yHPi4jKpx2AR+AAl1waSZ0BuP3Bm+APePnAXhwRU4AAt6hJltm U22TRdSxch7gBSZwBnOwBQGAD//XhV74hXRhR95GgK+gCfehYhbgA1SAAkXXF+ZAGWExgZjCFRoy b2ulXQ21gbaDD5SxaaCSMeDkN+rhAHeACChIDvEAJLfkQ1fTAAAQBWs3d/1AHo4RI55GAN90bkVw Bjdgb3XgAGXA/2FrmCcv8AIewD1aRibpgkzpoopqwl/ewUyQZyYbAIa2eIs7F2cYhiDbBlv2IgcS ZFUJ+AIFICFM8IYHgIZyuBVuVIfiQDT3hnkSEAT2UB7ZlCE5wDHSgEByED/q1gyIWAYugAPCEljG YgUmkGQuQwArAxAfSA46IgihcgDqdQZFIAjk0A0IMYqmWANf0HiKZx3pgi46sAFqYxRhkl/H9D3o kgAQgIsQGZFtdkAGAhV4pAp0QA58ZBcYFgI8MDgUeAC0koyfsIwTcoKD4WjmEAAKJQEiIiJHYzQu SVQZsjGNFAk50DJmtA3mwCtEcAK5Nl8U0ABEMANC4zLQ4DGxIv9NLTMIDhAj2KQyNOBhmyIOT0l3 CDEEb/B9NbBM1OE2alIUOgABJUFFDqkF6GISGaAEQoEGaCCRcBmXrHUMxmCRk/NzE3YMBLBTylg5 nkaSJjkhcER1nGYPLZl5ImJCZQBd2RQVcaRVn6ApfLIMExMjRXADJ4ADSTJeFHACNoAOhLBBlTAM GYQ+CgWK9hYOhdFhi2SHMZJ6IjAEskkGp8gmjUcdRAEc2+GQIzAUKhABWaAETJITclmcxjlOyFCX G2lAPnAeg4IMd9AHVKBAxiiScOhuUacMH2QhdugA90YqmXd7HziTf4gJj5mcx+h0AFdcDGFCJyAA RhJjHHACrnb/aIaACJTgMQ5Ad+/wQk/5l3VQAKx5aKRyAEVQA5z1AewwBDHAAx6ABUkIkCAAFGdy Jt2ilmigBEoQASNwnB76ofqDZ8FQCL1YCo4iKBBmDOxDBatXnbTiAHG4jIw2UImBgdFoezXney+T lAzUl1M1kkpmNyQ0BzgwAUZiNKlGBPLgMnvBQHbUevvJUzXyn/FAAxFHfTloTzXgAXmVeu5Tiqa4 ArGYRdXhkFRUkEyCBhCgBGqaBSD6pnCqOJQTDMxQopbCIaO3T3cgB5LRosaoKxEoh1PXaBxCAHXA SRq4gXLFkpr2dR+0jX5SKot0NzVqDibQAVaDpFLgAkfQh1DxuziYwnR0h4MH8Ikm1AVeEANnMANR 6QAe8ATlIZJFIAJktgIA0KA1gGwRCpbItBNsEAFGlBMJYARxWqzGmih4dinNSWemMFVxYAeiQJml eQF8gp1bAaiCiggWmBjicKguhHUvlIHk6TiB0Sk+Whc+sDIukzIoWKrimBtH+lBhsJjgUC/HRQny EVtMQALUxFOeFq4zIINkMARnsCkBAE00MzHtgwfJVgMMWwMiAEbIxia2CQIr8D1MkgAbEAgAIfkE BZABfwAsKwAnANABEwAAB/+AfoKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2XTKAWogompaUF eZ6qlKSmXQqrkA8msJqtpmWpsYmkhjSmpbWXv5ImNJ4ukUC7zM2RTHlMohYFGC6lJ9bO24bV1ybZ JtyIs8KY3tja44LVhiYYpiwYx8PikcbIkEDL6/3beXmmUcNwYFAXDA78OatWUNC7B/3KnFnF0CDC fu0KvRuUJ5suhZ2SOdrHj9COHVUErTm5Q+XJNZJWtsz0UlXNQTIVRRNYUdABDAVAMuvpxwHQfqUo Ehz0M+i6jIQ2DiIqVJNIRiRLDpIBRIagHSQFVdmnCOahsVot7UsZaY3ZRGv/CaFVFGoaUaNlBJH4 ZSIvxzKl/PohUYCE3sKDCwN+cAAVMT8HzpjoktBnYclnPuYB3JfQ3sCHiDb1o0DBgzP0Ik+uXEYw ab+qKQ8qfaCLiaCET5wooICwYT+bA+si/KDAZIiQERO6i0HY585+yji1nOrzK6aXTWQe9MC2dAzu wA+igQF57Mp+ChwATJkE5t+lZ5ei8bEVfXYNSdum8Tv9gVboKXKVIlml5QdY/HC1D0xgeXUWEDMZ MlcmcUECFluJVFHFW35MiAgoIDJBVBcsGJYHCy4UQB49fpjAgorz+LQUZEv9BI4JjcHjQjI/dVHA QZVVcxt5XQziIoz0nJji/4rdzOgHkC26wIJ2NPoI5UEfsTBRjz9e1OIJtx1UxiwsTEnDTw0dWcCU MrpAw5ossOOknA2RIKUuSiLpxxkY9OfCCcChCKNTQsJY5GCCkiheVIt2JBKXUPqBwQlnrGkNjPYk 5QcNLNDAKaCbdvqpIEelN08Bd5Lqgo8ulMfIgIgUaOCECgKRElczafgWroPoKhZZG54VrLCDrKWh XMcW4laFjmjo4RrJCsKEhnYAhA44LiBXBga6kCfIA80JckacNDaEJo32mDpdF1ddI2dlfH4b7p7k btvtolNhUKlx6ryTH7uDuKuAlz8lBLAg7rbIrSBgOmTPueBWZhREP9EzcP9BjfUnJwYcW9OfvYJ4 i5cgecQIcqjviiteNbq0Gl48XehysB8JY3DowLXE26I9MW66VM/kFVRqpyRj4Jc6JJQq4CKyGrjG Wk9DCKEfXGmYlQxr1CoDWvt4hZaCGHZ4NYcIxtX1Pi1lTRLWVEud1UwNCrJgXAgq+FVWKXENYR7X llmLbUwtdXJjMppbo5emZjldRlBlNLhTgBdeSDUda6mLCQO+mC9w+oa8sOZyOmxkpg8Ljq/R5UqO SDX7juvCb5GnziZprsb+E0SNizeztxrBU8qkyIFuKqlOnTv8zgy/XsgJyhNyFLj5TUb8IEonAmsh TRvoB9pjyRD3grziWvf/Dlxtbexa5RMS/tS/ArFSV9tDiOCBa6HddlcKbq0SsPBDjfb8aKlC+soX wJ50hFzgKIAC+VQQqBDCeOcy3vFIdRsFSiV3oXPHbhY4J1PlJyrpklQF+eUQUJ3gUPBQIAmRJzoW nsuBR4FgB5fjJHAdKoEcLAh5UtEFUGkqdRhk4QSNtCgbUlCFUimV8TKiqYFZbjYYeOL0JKgppVUP EdcrVvYOUT6woKR+y3CWAKfGK7p5by5x65WzeNW+HUArJedbBq/ilr74ha1qXrTjXNAIv7msxQK4 Igp5IOIiYJgAd/gKnOEw5iQYggkYGTyeA400JWAgJ18fHJ3zHmkKQWyL/wRJq8WkDNlCFmrqhacL igwzScMPSqWQlvQDuGDRsx+icnNCnKTCCCElUnGyisWbERPTNYsoCqOYLBClKp0ETOpNx3o0wZ+t 4hc3tZGkJWWcZq/IkkaV1Ip9d7OfHskyR/ixkVn0I9804yi2ZZQtLGthQiAbuZQf0vAQq0xdJCX1 TFxKMpGlXN0MhcjPQyStNQsrqDvSpalTLgWGy1xkIqjyyhASglITK+UtM/hDXUrFIeK54vT0OcxC HCBVTElVDJnJs+mI1BBZlITeBFGrljRIbdicGjr56KC7YY2NvVJQS9hZTq+cU5u/UqfcbLVHbnZF jHaUJ4SIUhEagIo0h/8sijDFYzyjMDI/DnTBREJmjyB6NYNWlc8l6XQIe4p1POk6YRcORbOxbop0 mnThUs5Ko4TkU6D5AZdI0ioIUiCHU2e4Ku8SN8GMEPZJAP3oLusK15EuUTxJKUfhNJu6o5TMpfSw Yj8PEVNJrC2c01xfToeaWgjxVH1kBGdO5kfUqdGRfeh8Wh3Z+VoBeiWe88zPtvJiFFiQoExFi1lH DmXEPLTqq/4MFUSMcqgglky5JxREcRFFrla2NYScmq7NxiMPwYRXqzdkaKZY4ADGLOW6gsCSPlGZ SdYtUB4SC9dxuwuunmk1L46KZEaMEpQHyCM8hDgIRM5LXctuVXQlM0H/KvgEEHhMeGGl+lMqtlUZ 0b5KE0JtX4Keaj8CEpCd3Wyb+WS7Ftoy1am2KjFuu8KhENuRmnaL2hiN2hUEVYEo4KIHnziWTChy 7ASXHDILtgXdfTq3Y0gW8KIGduQkV84cbF0oIZ5c5cD1iSOt6rIQNeUAeeBoRlTmWC3ySRVTdcwa ARqyMS/qqkHImQXICaLCJnUQBA+Cw8AJM/Ac3JCS0q5jtUjzvEpl4I7Z1cOLKG0kfLw/+LVTai1B yxdP+9ptog2c9zPbi5dhTRq3DW7opPSN60YW+pEkb2/zASNIcABW5qHWhmDMJBiz1kXcmpW0ZiUl eO0IYlvi1x/xRLANeaEbQyy72MKGdq8jgewt1zrZJj2AxiYh6U5Ai0MSGhYjvo2INzLCWZuIFk7U 7YMqxOEOoKyKvOdNb1n6t974bkS3881vS/jAB3SgQw5y0O+CG3wT25r2wfu974U7PBF5oANA6CDr h1v84ohQwGgxzvGOOxwgIM9DIAAAOw== ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/x-javascript Content-Transfer-Encoding: 7bit Content-Location: http://rmd.atdmt.com/tl/DocumentDotWrite.js function DocumentDotWrite(s){document.write(s);} ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://view.atdmt.com/IFR/iview/mdscpefr0120000007ifr/direct/01bWxdqbh,bdodfizlwAuK?click= EFX_20070622_round_5_v2_728x90

------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://as.medscape.com/html.ng/transactionid%3D1189189926510&site%3D1&pos%3D141&affiliate%3D1&artid%3D558835&pub%3D530&pubs%3D2036&ssp%3D12&cg%3D12

------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://as.medscape.com/html.ng/transactionid%3D1189189926510&site%3D1&pos%3D901&affiliate%3D1&artid%3D558835&pub%3D530&pubs%3D2036&ssp%3D12&cg%3D12

------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/x-javascript Content-Transfer-Encoding: quoted-printable Content-Location: http://www.medscape.com/files/scripts/header-footer.js var theTop =3D 75; var old =3D theTop; function opensearchradiobtns(stateradiobtn) { if (document.getElementById) { var radiobtns =3D document.getElementById("radioformheader"); if (document.getElementById("headertextinput").value =3D=3D " Search = Medscape, MEDLINE and Drug Reference") { document.getElementById("headertextinput").value =3D ""; } // Make sure the firstChild is an HTML tag and nothing else setElementClass(radiobtns, stateradiobtn); } } function opensearchradiobtns2(stateradiobtn) { if (document.getElementById) { var radiobtns =3D document.getElementById("radioformfooter"); if (document.getElementById("footertextinput").value =3D=3D " Search = Medscape, MEDLINE and Drug Reference") { document.getElementById("footertextinput").value =3D ""; =09 } // Make sure the firstChild is an HTML tag and nothing else setElementClass(radiobtns, stateradiobtn); } } function getElementClass(element) { if (element.getAttribute("class")) { return element.getAttribute("class"); } else if (element.getAttribute("className")) { return element.getAttribute("className"); } } function setElementClass(element, classValue) { if (element.setAttribute("class", classValue)) { element.setAttribute("class", classValue); } else if (element.setAttribute("className", classValue)) { element.setAttribute("className", classValue); } } function addalertlayer(continueURL) { var newDiv =3D parent.document.createElement("div"); newDiv.setAttribute("id", "cmesearchalert2"); continueURL=3DcontinueURL.replace(/\"/g,"""); newDiv.innerHTML =3D "

Medscape physician members have an = opportunity to earn CME credits for Internet Point of Care (PoC) through = self directed learning on topics relevant to clinical care. Physicians = participate in a 3 step learning cycle to receive a half (0.5) AMA = PRA Category 1 credit.

The 3 steps include:

Search = Medscape: Identify a clinical question by entering a search term
Learn: Review information sources = (search results)
Complete Action Plan: Briefly document how you = will implement learning in clinical practice

These = activities will be recorded in your CME Tracker with the 3 step = documentation available in print format on your certificate and CME = Tracker.

CANCEL CONTINUE »

"; var my_div =3D parent.document.getElementById("bodypadding"); parent.document.body.insertBefore(newDiv, my_div); document.getElementById("cmesearchalert2").style.top =3D '75px'; document.getElementById("cmesearchalert2").style.left =3D '150px'; document.getElementById("cmesearchalert2").style.position =3D = "absolute"; document.getElementById("cmesearchalert2").style.zIndex =3D 500; movelayerscmesearch('cmesearchalert2'); } function removealertlayer() { var element =3D document.getElementById("cmesearchalert2"); while (element.firstChild) { element.removeChild(element.firstChild); } document.getElementById("cmesearchalert2").id =3D ""; } function changeDivcmesearch(id, str) { if(!document.getElementById) return; // Not Supported =20 if(document.getElementById) { document.getElementById(id).innerHTML =3D str; document.getElementById("cmesearchalert").style.visibility =3D = "visible"; movelayerscmesearch(id); } } function popsearchalert(idname) { document.getElementById("cmesearchalert").style.top =3D '75px'; document.getElementById("cmesearchalert").style.left =3D '150px'; document.getElementById("cmesearchalert").style.position =3D = "absolute"; document.getElementById("cmesearchalert").style.zIndex =3D 500; searchalert =3D "

The 3 steps include:

Search = Medscape: Identify a clinical question by entering a search term
Learn: Review information sources = (search results)
Complete Action Plan: Briefly document how you = will implement learning in clinical practice

These = activities will be recorded in your CME Tracker with the 3 step = documentation available in print format on your certificate and CME = Tracker.

CLOSE"; incompletealert =3D "

Please note that in order to earn = AMA/PRA category 1 credit, you must first read at least one article from = your list of search results.

The 3 steps include:

Search = Medscape: Identify a clinical question by entering a search term
Learn: Review information sources = (search results)
Complete Action Plan: Briefly document how you = will implement learning in clinical practice

These = activities will be recorded in your CME Tracker with the 3 step = documentation available in print format on your certificate and CME = Tracker.

CLOSE"; emptydiv =3D "

"; if (idname =3D=3D "whatissearchcme") { changeDivcmesearch('cmesearchalert', searchalert); }else if (idname =3D=3D "incompletealert") { changeDivcmesearch('cmesearchalert', incompletealert);=09 } else if (idname =3D=3D "clearsearchcmealert") { changeDivcmesearch('cmesearchalert', emptydiv); } } function movelayerscmesearch(idx) { if (window.innerHeight) { pos =3D window.pageYOffset } else if (document.documentElement && = document.documentElement.scrollTop) { pos =3D document.documentElement.scrollTop } else if (document.body) { pos =3D document.body.scrollTop } =09 if (pos < theTop) { pos =3D theTop; } else { pos +=3D 75; } =09 if (pos =3D=3D old) { document.getElementById(idx).style.top =3D (pos + 'px'); document.getElementById(idx).style.left =3D '150px'; } else { old =3D pos; movelayerscmesearch(idx); } } ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/x-javascript Content-Transfer-Encoding: quoted-printable Content-Location: http://www.medscape.com/files/scripts/hp-pulldown.js function goToUrl(myUrl)=0A= {=0A= if (myUrl!=3D"")=0A= {=0A= parent.location.href=3DmyUrl;=0A= }=0A= }=0A= ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/x-javascript Content-Transfer-Encoding: quoted-printable Content-Location: http://www.medscape.com/files/scripts/popup.js function resizeWin(newLoc, newHeight, newWidth) {=0A= newWin =3D = open("",newLoc,"scrollbars=3Dyes,resizable=3Dyes,height=3D" + newHeight = + ",width=3D" + newWidth);=0A= }=0A= ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/x-javascript Content-Transfer-Encoding: quoted-printable Content-Location: http://www.medscape.com/files/scripts/swfobject.js /**=0A= * SWFObject v1.4.4: Flash Player detection and embed - = http://blog.deconcept.com/swfobject/=0A= *=0A= * SWFObject is (c) 2006 Geoff Stearns and is released under the MIT = License:=0A= * http://www.opensource.org/licenses/mit-license.php=0A= *=0A= * **SWFObject is the SWF embed script formerly known as FlashObject. = The name was changed for=0A= * legal reasons.=0A= */=0A= if(typeof deconcept =3D=3D "undefined") var deconcept =3D new Object();=0A= if(typeof deconcept.util =3D=3D "undefined") deconcept.util =3D new = Object();=0A= if(typeof deconcept.SWFObjectUtil =3D=3D "undefined") = deconcept.SWFObjectUtil =3D new Object();=0A= deconcept.SWFObject =3D function(swf, id, w, h, ver, c, = useExpressInstall, quality, xiRedirectUrl, redirectUrl, detectKey){=0A= if (!document.getElementById) { return; }=0A= this.DETECT_KEY =3D detectKey ? detectKey : 'detectflash';=0A= this.skipDetect =3D deconcept.util.getRequestParameter(this.DETECT_KEY);=0A= this.params =3D new Object();=0A= this.variables =3D new Object();=0A= this.attributes =3D new Array();=0A= if(swf) { this.setAttribute('swf', swf); }=0A= if(id) { this.setAttribute('id', id); }=0A= if(w) { this.setAttribute('width', w); }=0A= if(h) { this.setAttribute('height', h); }=0A= if(ver) { this.setAttribute('version', new = deconcept.PlayerVersion(ver.toString().split("."))); }=0A= this.installedVer =3D deconcept.SWFObjectUtil.getPlayerVersion();=0A= if(c) { this.addParam('bgcolor', c); }=0A= var q =3D quality ? quality : 'high';=0A= this.addParam('quality', q);=0A= this.setAttribute('useExpressInstall', useExpressInstall);=0A= this.setAttribute('doExpressInstall', false);=0A= var xir =3D (xiRedirectUrl) ? xiRedirectUrl : window.location;=0A= this.setAttribute('xiRedirectUrl', xir);=0A= this.setAttribute('redirectUrl', '');=0A= if(redirectUrl) { this.setAttribute('redirectUrl', redirectUrl); }=0A= }=0A= deconcept.SWFObject.prototype =3D {=0A= setAttribute: function(name, value){=0A= this.attributes[name] =3D value;=0A= },=0A= getAttribute: function(name){=0A= return this.attributes[name];=0A= },=0A= addParam: function(name, value){=0A= this.params[name] =3D value;=0A= },=0A= getParams: function(){=0A= return this.params;=0A= },=0A= addVariable: function(name, value){=0A= this.variables[name] =3D value;=0A= },=0A= getVariable: function(name){=0A= return this.variables[name];=0A= },=0A= getVariables: function(){=0A= return this.variables;=0A= },=0A= getVariablePairs: function(){=0A= var variablePairs =3D new Array();=0A= var key;=0A= var variables =3D this.getVariables();=0A= for(key in variables){=0A= variablePairs.push(key +"=3D"+ variables[key]);=0A= }=0A= return variablePairs;=0A= },=0A= getSWFHTML: function() {=0A= var swfNode =3D "";=0A= if (navigator.plugins && navigator.mimeTypes && = navigator.mimeTypes.length) { // netscape plugin architecture=0A= if (this.getAttribute("doExpressInstall")) { = this.addVariable("MMplayerType", "PlugIn"); }=0A= swfNode =3D '

';=0A= } else { // PC IE=0A= if (this.getAttribute("doExpressInstall")) { = this.addVariable("MMplayerType", "ActiveX"); }=0A= swfNode =3D '

";=0A= }=0A= return swfNode;=0A= },=0A= write: function(elementId){=0A= if(this.getAttribute('useExpressInstall')) {=0A= // check to see if we need to do an express install=0A= var expressInstallReqVer =3D new deconcept.PlayerVersion([6,0,65]);=0A= if (this.installedVer.versionIsValid(expressInstallReqVer) && = !this.installedVer.versionIsValid(this.getAttribute('version'))) {=0A= this.setAttribute('doExpressInstall', true);=0A= this.addVariable("MMredirectURL", = escape(this.getAttribute('xiRedirectUrl')));=0A= document.title =3D document.title.slice(0, 47) + " - Flash Player = Installation";=0A= this.addVariable("MMdoctitle", document.title);=0A= }=0A= }=0A= if(this.skipDetect || this.getAttribute('doExpressInstall') || = this.installedVer.versionIsValid(this.getAttribute('version'))){=0A= var n =3D (typeof elementId =3D=3D 'string') ? = document.getElementById(elementId) : elementId;=0A= n.innerHTML =3D this.getSWFHTML();=0A= return true;=0A= }else{=0A= if(this.getAttribute('redirectUrl') !=3D "") {=0A= document.location.replace(this.getAttribute('redirectUrl'));=0A= }=0A= }=0A= return false;=0A= }=0A= }=0A= =0A= /* ---- detection functions ---- */=0A= deconcept.SWFObjectUtil.getPlayerVersion =3D function(){=0A= var PlayerVersion =3D new deconcept.PlayerVersion([0,0,0]);=0A= if(navigator.plugins && navigator.mimeTypes.length){=0A= var x =3D navigator.plugins["Shockwave Flash"];=0A= if(x && x.description) {=0A= PlayerVersion =3D new = deconcept.PlayerVersion(x.description.replace(/([a-zA-Z]|\s)+/, = "").replace(/(\s+r|\s+b[0-9]+)/, ".").split("."));=0A= }=0A= }else{=0A= // do minor version lookup in IE, but avoid fp6 crashing issues=0A= // see = http://blog.deconcept.com/2006/01/11/getvariable-setvariable-crash-intern= et-explorer-flash-6/=0A= try{=0A= var axo =3D new ActiveXObject("ShockwaveFlash.ShockwaveFlash.7");=0A= }catch(e){=0A= try {=0A= var axo =3D new ActiveXObject("ShockwaveFlash.ShockwaveFlash.6");=0A= PlayerVersion =3D new deconcept.PlayerVersion([6,0,21]);=0A= axo.AllowScriptAccess =3D "always"; // throws if player version < = 6.0.47 (thanks to Michael Williams @ Adobe for this code)=0A= } catch(e) {=0A= if (PlayerVersion.major =3D=3D 6) {=0A= return PlayerVersion;=0A= }=0A= }=0A= try {=0A= axo =3D new ActiveXObject("ShockwaveFlash.ShockwaveFlash");=0A= } catch(e) {}=0A= }=0A= if (axo !=3D null) {=0A= PlayerVersion =3D new = deconcept.PlayerVersion(axo.GetVariable("$version").split(" = ")[1].split(","));=0A= }=0A= }=0A= return PlayerVersion;=0A= }=0A= deconcept.PlayerVersion =3D function(arrVersion){=0A= this.major =3D arrVersion[0] !=3D null ? parseInt(arrVersion[0]) : 0;=0A= this.minor =3D arrVersion[1] !=3D null ? parseInt(arrVersion[1]) : 0;=0A= this.rev =3D arrVersion[2] !=3D null ? parseInt(arrVersion[2]) : 0;=0A= }=0A= deconcept.PlayerVersion.prototype.versionIsValid =3D function(fv){=0A= if(this.major < fv.major) return false;=0A= if(this.major > fv.major) return true;=0A= if(this.minor < fv.minor) return false;=0A= if(this.minor > fv.minor) return true;=0A= if(this.rev < fv.rev) return false;=0A= return true;=0A= }=0A= /* ---- get value of query string param ---- */=0A= deconcept.util =3D {=0A= getRequestParameter: function(param) {=0A= var q =3D document.location.search || document.location.hash;=0A= if(q) {=0A= var pairs =3D q.substring(1).split("&");=0A= for (var i=3D0; i < pairs.length; i++) {=0A= if (pairs[i].substring(0, pairs[i].indexOf("=3D")) =3D=3D param) {=0A= return pairs[i].substring((pairs[i].indexOf("=3D")+1));=0A= }=0A= }=0A= }=0A= return "";=0A= }=0A= }=0A= /* fix for video streaming bug */=0A= deconcept.SWFObjectUtil.cleanupSWFs =3D function() {=0A= if (window.opera || !document.all) return;=0A= var objects =3D document.getElementsByTagName("OBJECT");=0A= for (var i=3D0; i < objects.length; i++) {=0A= objects[i].style.display =3D 'none';=0A= for (var x in objects[i]) {=0A= if (typeof objects[i][x] =3D=3D 'function') {=0A= objects[i][x] =3D function(){};=0A= }=0A= }=0A= }=0A= }=0A= // fixes bug in fp9 see = http://blog.deconcept.com/2006/07/28/swfobject-143-released/=0A= deconcept.SWFObjectUtil.prepUnload =3D function() {=0A= __flash_unloadHandler =3D function(){};=0A= __flash_savedUnloadHandler =3D function(){};=0A= if (typeof window.onunload =3D=3D 'function') {=0A= var oldUnload =3D window.onunload;=0A= window.onunload =3D function() {=0A= deconcept.SWFObjectUtil.cleanupSWFs();=0A= oldUnload();=0A= }=0A= } else {=0A= window.onunload =3D deconcept.SWFObjectUtil.cleanupSWFs;=0A= }=0A= }=0A= if (typeof window.onbeforeunload =3D=3D 'function') {=0A= var oldBeforeUnload =3D window.onbeforeunload;=0A= window.onbeforeunload =3D function() {=0A= deconcept.SWFObjectUtil.prepUnload();=0A= oldBeforeUnload();=0A= }=0A= } else {=0A= window.onbeforeunload =3D deconcept.SWFObjectUtil.prepUnload;=0A= }=0A= /* add Array.push if needed (ie5) */=0A= if (Array.prototype.push =3D=3D null) { Array.prototype.push =3D = function(item) { this[this.length] =3D item; return this.length; }}=0A= =0A= /* add some aliases for ease of use/backwards compatibility */=0A= var getQueryParamValue =3D deconcept.util.getRequestParameter;=0A= var FlashObject =3D deconcept.SWFObject; // for legacy support=0A= var SWFObject =3D deconcept.SWFObject;=0A= ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/x-javascript Content-Transfer-Encoding: quoted-printable Content-Location: http://www.medscape.com/files/scripts/articletools.js var theTop =3D 75;=0A= var old =3D theTop;=0A= =0A= window.onload =3D function() {=0A= hidearticletools();=0A= hidecontent();=0A= hiddenlayers();=0A= }=0A= =0A= function hidearticletools()=0A= {=0A= if (document.getElementById('emailtoolbox')) {=0A= document.getElementById('emailtoolbox').style.display =3D "none";=0A= }=0A= if (document.getElementById('ratingtoolbox')) {=0A= document.getElementById('ratingtoolbox').style.display =3D "none";=0A= }=0A= if (document.getElementById('emailconfirmation')) {=0A= document.getElementById('emailconfirmation').style.display =3D "none";=0A= }=0A= if (document.getElementById('ratingthanks')) {=0A= document.getElementById('ratingthanks').style.display =3D "none";=0A= }=0A= if (document.getElementById('ratingthanks2')) {=0A= document.getElementById('ratingthanks2').style.display =3D "none";=0A= }=0A= if (document.getElementById('synonymskeywords')) {=0A= document.getElementById('synonymskeywords').style.display =3D "none";=0A= }=0A= }=0A= =0A= function hidecontent()=0A= {=0A= if (document.getElementById('references')) {=0A= document.getElementById('references').style.display =3D "none";=0A= document.getElementById('references').style.top =3D '75px';=0A= document.getElementById('references').style.left =3D '150px';=0A= document.getElementById('references').style.position =3D "absolute";=0A= document.getElementById('references').style.zIndex =3D 500;=0A= }=0A= if (document.getElementById('suggestedreading')) {=0A= document.getElementById('suggestedreading').style.display =3D "none";=0A= document.getElementById('suggestedreading').style.top =3D '75px';=0A= document.getElementById('suggestedreading').style.left =3D '150px';=0A= document.getElementById('suggestedreading').style.position =3D = "absolute";=0A= document.getElementById('suggestedreading').style.zIndex =3D 500; =0A= }=0A= if (document.getElementById('relatedlinkswin')) {=0A= document.getElementById('relatedlinkswin').style.display =3D "none";=0A= document.getElementById('relatedlinkswin').style.top =3D '75px';=0A= document.getElementById('relatedlinkswin').style.left =3D '150px';=0A= document.getElementById('relatedlinkswin').style.position =3D = "absolute";=0A= document.getElementById('relatedlinkswin').style.zIndex =3D 500; =0A= }=0A= if (document.getElementById('cmeinformation')) {=0A= document.getElementById('cmeinformation').style.display =3D "none";=0A= document.getElementById('cmeinformation').style.top =3D '75px';=0A= document.getElementById('cmeinformation').style.left =3D '150px';=0A= document.getElementById('cmeinformation').style.position =3D = "absolute";=0A= document.getElementById('cmeinformation').style.zIndex =3D 500; =0A= }=0A= if (document.getElementById('authordisclosures')) {=0A= document.getElementById('authordisclosures').style.display =3D "none";=0A= document.getElementById('authordisclosures').style.top =3D '75px';=0A= document.getElementById('authordisclosures').style.left =3D '150px';=0A= document.getElementById('authordisclosures').style.position =3D = "absolute";=0A= document.getElementById('authordisclosures').style.zIndex =3D 500; = =0A= }=0A= }=0A= =0A= function showcontent(tent) {=0A= if (document.getElementById(tent).style.display =3D=3D "none") {=0A= hidecontent();=0A= document.getElementById(tent).style.display =3D "block";=0A= document.getElementById(tent).style.height =3D "auto";=0A= movelayers(tent);=0A= } else {=0A= document.getElementById(tent).style.display =3D "none";=0A= }=0A= }=0A= =0A= function movecontent(tent)=0A= {=0A= if (window.innerHeight)=0A= {=0A= pos =3D window.pageYOffset=0A= }=0A= else if (document.documentElement && document.documentElement.scrollTop)=0A= {=0A= pos =3D document.documentElement.scrollTop=0A= }=0A= else if (document.body)=0A= {=0A= pos =3D document.body.scrollTop=0A= }=0A= =0A= if (pos < theTop)=0A= {=0A= pos =3D theTop;=0A= }=0A= else=0A= {=0A= pos +=3D 75;=0A= }=0A= =0A= if (pos =3D=3D old)=0A= {=0A= document.getElementById(tent).style.top =3D (pos + 'px');=0A= document.getElementById(tent).style.left =3D '150px';=0A= }=0A= else=0A= {=0A= old =3D pos;=0A= movelayers(tent);=0A= }=0A= }=0A= =0A= =0A= function hiddenlayers() {=0A= var displaystr =3D null;=0A= var stylestr =3D null;=0A= =0A= for(n =3D1; n < 100; n++){=0A= if(n <10)=0A= displaystr =3D 'hiddenlayer0' + n;=0A= else=0A= displaystr =3D 'hiddenlayer' + n;=0A= stylestr =3D document.getElementById(displaystr);=0A= if(stylestr !=3D null) {=0A= stylestr.style.display =3D "none";=0A= stylestr.style.top =3D '75px';=0A= stylestr.style.left =3D '150px';=0A= stylestr.style.position =3D "absolute";=0A= stylestr.style.zIndex =3D 500;=0A= } =0A= else=0A= break;=0A= }=0A= }=0A= =0A= function showlayers(num) {=0A= if (document.getElementById(num).style.display =3D=3D "none") {=0A= hiddenlayers();=0A= document.getElementById(num).style.display =3D "block";=0A= document.getElementById(num).style.height =3D "auto";=0A= movelayers(num);=0A= } else {=0A= document.getElementById(num).style.display =3D "none";=0A= }=0A= }=0A= =0A= function movelayers(num)=0A= {=0A= if (window.innerHeight)=0A= {=0A= pos =3D window.pageYOffset=0A= }=0A= else if (document.documentElement && document.documentElement.scrollTop)=0A= {=0A= pos =3D document.documentElement.scrollTop=0A= }=0A= else if (document.body)=0A= {=0A= pos =3D document.body.scrollTop=0A= }=0A= =0A= if (pos < theTop)=0A= {=0A= pos =3D theTop;=0A= }=0A= else=0A= {=0A= pos +=3D 75;=0A= }=0A= =0A= if (pos =3D=3D old)=0A= {=0A= document.getElementById(num).style.top =3D (pos + 'px');=0A= document.getElementById(num).style.left =3D '150px';=0A= }=0A= else=0A= {=0A= old =3D pos;=0A= movelayers(num);=0A= }=0A= }=0A= =0A= function showemailtoolbox()=0A= {=0A= if (document.getElementById('emailtoolbox').style.display =3D=3D "none")=0A= {=0A= document.getElementById('emailtoolbox').style.display =3D "block";=0A= if (document.getElementById('ratingtoolbox')) {=0A= document.getElementById('ratingtoolbox').style.display =3D "none";=0A= }=0A= }=0A= else=0A= {=0A= document.getElementById('emailtoolbox').style.display =3D "none";=0A= }=0A= =0A= }=0A= =0A= function confirmsent()=0A= {=0A= if (document.getElementById('emailconfirmation').style.display =3D=3D = "none")=0A= {=0A= document.getElementById('emailconfirmation').style.display =3D "block";=0A= document.getElementById('emailform').style.display =3D "none";=0A= return false;=0A= }=0A= } ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://as.medscape.com/js.ng/transactionid%3D1189189926510&site%3D1&pos%3D121&affiliate%3D1&artid%3D558835&pub%3D530&pubs%3D2036&ssp%3D12&cg%3D12 document.write('');=0A= if ("html" =3D=3D "html"){ =0A= document.bgColor =3D 'transparent';=0A= }=0A= document.write('

Information from Industry

\n\nAssess clinically focused product information on = Medscape.\n

\nClick Here = for Product Infosites -- Information from = Industry.\n

\n\n\n

\n'); ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://as.medscape.com/js.ng/transactionid%3D1189189926510&site%3D1&pos%3D122&affiliate%3D1&artid%3D558835&pub%3D530&pubs%3D2036&ssp%3D12&cg%3D12 document.write('');=0A= if ("html" =3D=3D "html"){ =0A= document.bgColor =3D 'transparent';=0A= }=0A= document.write('

\n'); ------=_NextPart_000_0000_01C7F153.77C901F0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://img.webmd.com/bi_common/bi_medscape.js?d=09/07/2007 var s_live=3Dfalse; try { if (s_account =3D=3D "webmddev") { = s_account=3D"webmdp1medscapevistadev";s_live=3Dfalse;}=20 else {s_account=3D"webmdp1global"; s_live=3Dtrue;} } catch(e) {var s_account=3D"webmdp1global"; s_live=3Dtrue; } var s_md=3Ds_gi(s_account) s_md.cookieDomainPeriods=3D"3" s_md.jsCookieDomainPeriods=3D"2" s_md.charSet=3D"ISO-8859-1" s_md.currencyCode=3D"USD" s_md.trackDownloadLinks=3Dtrue s_md.trackExternalLinks=3Dtrue s_md.trackInlineStats=3Dtrue s_md.linkDownloadFileTypes=3D"exe,zip,wav,mp3,mov,mpg,avi,wmv,doc,pdf,xls= " s_md.linkInternalFilters=3D"javascript:,.medscape.com" s_md.linkLeaveQueryString=3Dfalse s_md.linkTrackVars=3D"prop50" s_md.linkTrackEvents=3D"None" s_md.visitorNamespace=3D"webmd" s_md.usePlugins=3Dtrue function s_md_doPlugins(s) { if (!s_md.pageName) { s_md.pageName=3Dlocation.protocol + "//" + location.host + = location.pathname; } } s_md.doPlugins=3Ds_md_doPlugins s_md.c_gd=3Dnew Function("" +"var = s=3Dthis,d=3Ds.wd.location.hostname,n=3Ds.jsCookieDomainPeriods,n2=3Ds." +"cookieDomainPeriods,p;if(d&&!s.c_d){n=3Dn?n:n2;n=3Dn?parseInt(n):2;n=3D= n>" +"2?n:2;p=3Dd.lastIndexOf('.');while(p>=3D0&&n>1){p=3Dd.lastIndexOf('.',p= -1" +");n--}s.c_d=3Dp>0&&s.pt(d,'.','c_gdf',0)?d.substring(p):'';}return s." +"c_d"); s_md.trackGAS=3Dnew Function("" +"var = s_md=3Dthis,gifa=3Ddocument.getElementsByTagName('iframe'),gif;for(v" +"ar = i=3D0;i-1){gif=3Dgifa[i];if(gif.attachEvent){gif.attachEvent('onfocus',"= +"s_md.gasf);}}}"); s_md.gasf=3Dnew Function("" +"var = s_md=3Ds_gi(s_account);s_md.prop36=3Ds_md.pageName;s.tl(true,'o','Go" +"ogle Exit Link');"); /* Google AdSense Tracking */ s_md.trackGAS(); /* WEBMD code for Medscape start here */ var s_bu=3D"pro"; var s_siteclass=3D"oop"; var s_site=3D"medscape"; function _clean(a) { = //a=3Da.split("/").join("-");a=3Da.split("&").join("-");a=3Da.split("?").= join("-"); a=3Da.toLowerCase(); return a; } function _urlClean(a) = {a=3Da.toLowerCase();a=3Da.split("https://www.").join("");a=3Da.split("ht= tp://www.").join(""); a=3Da.split("https://").join("");a=3Da.split("http://").join(""); //a=3Da.split("|").join("-");a=3Da.split("'").join(""); //a=3Da.split("#").join("-");a=3Da.split("$").join("-");a=3Da.split("%").= join("");a=3Da.split("^").join(""); //a=3Da.split("*").join("");a=3Da.split(":").join("");a=3Da.split("!").jo= in("");a=3Da.split("<").join(""); //a=3Da.split(">").join("");a=3Da.split("~").join("");a=3Da.split(";").jo= in("");a=3Da.split(" ").join("+"); a=3Da.split(".html").join("");a=3Da.split(".htm").join("");a=3Da.split(".= aspx").join("");a=3Da.split(".asp").join("");a=3Da.split(".jsp").join("")= ; return a; } function _readC(name) { var qName =3D name + "=3D"; var ca =3D document.cookie.split(';'); for(var i=3D0;i < ca.length;i++) { var c =3D ca[i]; while (c.charAt(0)=3D=3D' ') c =3D c.substring(1,c.length); if (c.indexOf(qName) =3D=3D 0) return = c.substring(qName.length,c.length); } return ""; } function _writeC(sName, sValue) { date =3D new Date(3000, 1, 1, 0, 0, 0); document.cookie =3D sName + "=3D" + escape(sValue) + "; expires=3D" + = date.toGMTString(); } function _readQ(name) { var qName =3D name.toLowerCase() + "=3D"; if (document.URL.indexOf("?")=3D=3D-1) { return ""; } var _url =3D document.URL.split('?'); var ca =3D String(_url[1]).toLowerCase().split('&'); for(var i=3D0;i < ca.length;i++) { var c =3D ca[i]; while (c.charAt(0)=3D=3D' ') c =3D c.substring(1,c.length); if (c.indexOf(qName) =3D=3D 0) return = c.substring(qName.length,c.length); } return ""; } var _URL =3D ""; try{ _URL=3Ds_pagename; } catch (e){} try{ _URL=3Ds_pageName; } catch (e){} if (_URL=3D=3D"") { _URL1=3DString(document.location).split("?");=20 _URL2=3D_URL1[0].split(";"); _URL=3D_URL2[0];=20 } _URL=3D_urlClean(_URL); var _asset =3D _URL.substr(_URL.indexOf("/")+1); _asset =3D String(_clean(_asset)); var s_query=3D""; var s_filter=3D""; var s_pagenum=3D""; if (!s_query){=20 s_query =3D _readQ("querytext"); if (s_query) { s_filter=3D"drug"; } s_pagenum=3D"1"; } try{if(_readQ("pagenumber")>1){s_pagenum=3D_readQ("pagenumber");}}catch(e= ){} var _prop47fromPage=3D""; if(!s_user_origin){var s_user_origin=3D"";} if(_readC("medauth")!=3D""){ //logged in user if(s_user_origin.toLowerCase()=3D=3D"us"){ try{ if(s_user_group.toLowerCase()=3D=3D"physician") { = _prop47fromPage=3D"us-physician"; } = else{_prop47fromPage=3D"us-other";}}catch(e){} }else{ try{ if(s_user_group.toLowerCase()=3D=3D"physician") { = _prop47fromPage=3D"non-us-physician"; } = else{_prop47fromPage=3D"non-us-other";}}catch(e){} } s_md.eVar4=3D_prop47fromPage; }else if(_readC("medpermauth")!=3D""){ //not logged in user s_user_group=3D"undefined"; s_user_origin=3D"undefined"; } else{ //cookies are not accepted user s_user_group=3D"undefined"; s_user_origin=3D"undefined"; } s_md.prop50=3D"webmdp1medscapevista"; s_md.hier1=3D"webmd,pro,oop,medscape,-"; try{if (s_not_pageview) {if (s_not_pageview!=3D"n") = {s_not_pageview=3D"y";}} else {var s_not_pageview=3D"n";}}=20 catch (e){var s_not_pageview=3D"n";} if(!s_print){ if(_readQ("prt")=3D=3D'true'){var s_print=3D1;} if(_URL.indexOf('_print')>0){var s_print=3D1;} } s_md.pageName=3D_URL; try{s_md.prop1=3Ds_bu.toLowerCase();}catch(e){} try{s_md.prop2=3Ds_siteclass.toLowerCase();}catch(e){} try{s_md.prop3=3Ds_site.toLowerCase();}catch(e){} try{s_md.prop4=3Ds_channel;s_md.channel=3Ds_channel;}catch(e){} try{s_md.prop5=3Ds_asset_type.toLowerCase();}catch(e){} try{s_md.prop6=3Ds_asset_class.toLowerCase();}catch(e){} try{s_md.prop7=3D_asset.toLowerCase();}catch(e){} try{s_md.prop8=3Ds_pub.toLowerCase();}catch(e){s_md.prop8=3D"-";} try{s_md.prop9=3Ds_pagenum;}catch(e){} try{s_md.eVar1=3Ds_query.toLowerCase(); s_md.prop10=3Ds_query;}catch (e) = {} try{s_md.eVar2=3Ds_filter.toLowerCase(); s_md.prop11=3Ds_filter;}catch = (e) {} try{s_md.prop12=3Ds_results;}catch(e){} try{s_md.prop13=3Ds_spell;}catch(e){} try{s_md.prop14=3Ds_g_ads;}catch(e){} try{if (s_campaign){s_md.prop15=3Ds_campaign; s_md.campaign=3D"z:"+s_campaign;}}catch(e){} try{if (s_rss){ s_md.prop16=3Ds_rss; s_md.campaign=3D"rss:"+s_rss;}}catch(e){} try{s_md.prop17=3Ds_sponsor.toLowerCase();}catch(e){} try{s_md.prop18=3Ds_product.toLowerCase();}catch(e){} try{s_md.prop19=3Ds_user_group.toLowerCase();}catch(e){} try{s_md.prop22=3Ds_print;}catch(e){} try{s_md.prop23=3Ds_board;}catch(e){} try{s_md.prop24=3Ds_refpath.toLowerCase();}catch(e){} try{s_md.prop25=3Ds_override.toLowerCase();}catch(e){} try{if (s_error !=3D ""){ s_md.pageType=3D"errorPage"; = try{if(s_error_url){s_md.pageName=3Ds_error_asset;s_md.pageURL=3Ds_error_= url}}catch(e){} try{s_md.prop26=3Ds_error_referer;}catch(e){} } } catch(e){} try{s_md.prop37=3Ds_user_origin.toLowerCase();}catch(e){} try{s_md.prop38=3Ds_user_specialty.toLowerCase();}catch(e){} try{s_md.prop35=3Ds_content_type.toLowerCase();}catch(e){} try{s_md.prop36=3Ds_sponsor_content.toLowerCase();}catch(e){} = try{s_md.prop47=3Ds_registered_user_id.toLowerCase();}catch(e){s_md.prop4= 7=3D"000000000";} try{if (s_create_date!=3D"Undefined") {s_md.prop48=3Ds_create_date + " = 00:00:00";} }catch(e){} try{s_md.server=3Ds_server_type.toLowerCase();}catch(e){try{s_md.server=3D= s_server;}catch(e){}} try{s_md.server=3Ds_md.server+s_server_location;}catch(e){} try{s_md.server=3Ds_md.server+s_server_number;}catch(e){} /* End of WebMD Code */ /************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/ var s_objectID;function s_c2fe(f){var x=3D'',s=3D0,e,a,b,c;while(1){e=3D f.indexOf('"',s);b=3Df.indexOf('\\',s);c=3Df.indexOf("\n",s);if(e<0||(b>=3D= 0&&b=3D0&&c=3D0){x+=3D(e>s?f.substrin= g(s,e): '')+(e=3D=3Dc?'\\n':'\\'+f.substring(e,e+1));s=3De+1}else return x +f.substring(s)}return f}function s_c2fa(f){var = s=3Df.indexOf('(')+1,e=3D f.indexOf(')'),a=3D'',c;while(s>=3D0&&s=3D0){d=3D1;q=3D'';x=3D0;f=3Dc.substring(s)= ;a=3D s_c2fa(f);e=3Do=3Dc.indexOf('{',s);e++;while(d>0){h=3Dc.substring(e,e+1);= if( q){if(h=3D=3Dq&&!x)q=3D'';if(h=3D=3D'\\')x=3Dx?0:1;else = x=3D0}else{if(h=3D=3D'"'||h=3D=3D"'" )q=3Dh;if(h=3D=3D'{')d++;if(h=3D=3D'}')d--}if(d>0)e++}c=3Dc.substring(0,s= ) +'new Function('+(a?a+',':'')+'"'+s_c2fe(c.substring(o+1,e))+'")' +c.substring(e+1);s=3Dc.indexOf('function')}fc+=3Ds_c2fe(c)+';return = s");' eval(fc);return f}function s_gi(un,pg,ss){var c=3D"function s_c(un,pg,s" +"s){var s=3Dthis;s.wd=3Dwindow;if(!s.wd.s_c_in){s.wd.s_c_il=3Dnew = Array;s." +"wd.s_c_in=3D0;}s._il=3Ds.wd.s_c_il;s._in=3Ds.wd.s_c_in;s._il[s._in]=3Ds= ;s.w" +"d.s_c_in++;s.m=3Dfunction(m){return = (''+m).indexOf('{')<0};s.fl=3Dfunct" +"ion(x,l){return x?(''+x).substring(0,l):x};s.co=3Dfunction(o){if(!o)r" +"eturn o;var n=3Dnew Object,x;for(x in o)if(x.indexOf('select')<0&&x.i" +"ndexOf('filter')<0)n[x]=3Do[x];return = n};s.num=3Dfunction(x){x=3D''+x;for" +"(var p=3D0;p0?n.length:1;while(x&&i>=3D0){x=3Dx.substring(0,i)+n+x.substri= " +"ng(i+o.length);i=3Dx.indexOf(o,i+l)}return x};s.ape=3Dfunction(x){var = s" +"=3Dthis,i;x=3Dx?s.rep(escape(''+x),'+','%2B'):x;if(x&&s.charSet&&s.em=3D= =3D" +"1&&x.indexOf('%u')<0&&x.indexOf('%U')<0){i=3Dx.indexOf('%');while(i>=3D= " +"0){i++;if(('89ABCDEFabcdef').indexOf(x.substring(i,i+1))>=3D0)return " +"x.substring(0,i)+'u00'+x.substring(i);i=3Dx.indexOf('%',i)}}return x}" +";s.epa=3Dfunction(x){var s=3Dthis;return x?unescape(s.rep(''+x,'+',' = ')" +"):x};s.pt=3Dfunction(x,d,f,a){var = s=3Dthis,t=3Dx,z=3D0,y,r;while(t){y=3Dt.ind" +"exOf(d);y=3Dy<0?t.length:y;t=3Dt.substring(0,y);r=3Ds.m(f)?s[f](t,a):f(= t," +"a);if(r)return = r;z+=3Dy+d.length;t=3Dx.substring(z,x.length);t=3Dz=3D0" +")a=3Da.substring(0,c);if(t.substring(0,2)=3D=3D's_')t=3Dt.substring(2);= retu" +"rn (t!=3D''&&t=3D=3Da)};s.fsf=3Dfunction(t,a){var = s=3Dthis;if(s.pt(a,',','isf" +"',t))s.fsg+=3D(s.fsg!=3D''?',':'')+t;return = 0};s.fs=3Dfunction(x,f){var s" +"=3Dthis;s.fsg=3D'';s.pt(x,',','fsf',f);return = s.fsg};s.c_d=3D'';s.c_gdf=3Df" +"unction(t,a){var s=3Dthis;if(!s.num(t))return 1;return = 0};s.c_gd=3Dfunc" +"tion(){var = s=3Dthis,d=3Ds.wd.location.hostname,n=3Ds.cookieDomainPeriods," +"p;if(d&&!s.c_d){n=3Dn?parseInt(n):2;n=3Dn>2?n:2;p=3Dd.lastIndexOf('.');= wh" +"ile(p>=3D0&&n>1){p=3Dd.lastIndexOf('.',p-1);n--}s.c_d=3Dp>0&&s.pt(d,'.'= ,'" +"c_gdf',0)?d.substring(p):''}return s.c_d};s.c_r=3Dfunction(k){var = s=3Dt" +"his;k=3Ds.ape(k);var c=3D' '+s.d.cookie,i=3Dc.indexOf(' = '+k+'=3D'),e=3Di<0?i:" +"c.indexOf(';',i),v=3Di<0?'':s.epa(c.substring(i+2+k.length,e<0?c.leng" +"th:e));return v!=3D'[[B]]'?v:''};s.c_w=3Dfunction(k,v,e){var = s=3Dthis,d=3Ds" +".c_gd(),l=3Ds.cookieLifetime,t;v=3D''+v;l=3Dl?(''+l).toUpperCase():'';i= f(" +"e&&l!=3D'SESSION'&&l!=3D'NONE'){t=3D(v!=3D''?parseInt(l?l:0):-60);if(t)= {e=3Dn" +"ew Date;e.setTime(e.getTime()+(t*1000))}}if(k&&l!=3D'NONE'){s.d.cooki" +"e=3Dk+'=3D'+s.ape(v!=3D''?v:'[[B]]')+'; = path=3D/;'+(e&&l!=3D'SESSION'?' expir" +"es=3D'+e.toGMTString()+';':'')+(d?' domain=3D'+d+';':'');return = s.c_r(k" +")=3D=3Dv}return 0};s.eh=3Dfunction(o,e,r,f){var = s=3Dthis,b=3D's_'+e+'_'+s._in" +",n=3D-1,l,i,x;if(!s.ehl)s.ehl=3Dnew = Array;l=3Ds.ehl;for(i=3D0;i=3D5)eval('try{r=3Ds.m(f)?s[f](a):f(a)}catch(e){r=3Ds.= m(" +"t)?s[t](e):t(e)}');else{if(s.ismac&&s.u.indexOf('MSIE = 4')>=3D0)r=3Ds.m(" +"b)?s[b](a):b(a);else{s.eh(s.wd,'onerror',0,o);r=3Ds.m(f)?s[f](a):f(a)" +";s.eh(s.wd,'onerror',1)}}return r};s.gtfset=3Dfunction(e){var = s=3Dthis;" +"return s.tfs};s.gtfsoe=3Dnew Function('e','var = s=3Ds_c_il['+s._in+'];s." +"eh(window,\"onerror\",1);s.etfs=3D1;var = c=3Ds.t();if(c)s.d.write(c);s.e" +"tfs=3D0;return true');s.gtfsfb=3Dfunction(a){return = window};s.gtfsf=3Dfun" +"ction(w){var = s=3Dthis,p=3Dw.parent,l=3Dw.location;s.tfs=3Dw;if(p&&p.locatio" +"n!=3Dl&&p.location.host=3D=3Dl.host){s.tfs=3Dp;return = s.gtfsf(s.tfs)}return" +" s.tfs};s.gtfs=3Dfunction(){var = s=3Dthis;if(!s.tfs){s.tfs=3Ds.wd;if(!s.et" +"fs)s.tfs=3Ds.cet('gtfsf',s.tfs,'gtfset',s.gtfsoe,'gtfsfb')}return s.t" +"fs};s.ca=3Dfunction(){var = s=3Dthis,imn=3D's_i_'+s.fun;if(s.d.images&&s.ap" +"v>=3D3&&!s.isopera&&(s.ns6<0||s.apv>=3D6.1)){s.ios=3D1;if(!s.d.images[i= mn" +"]&&(!s.isns||(s.apv<4||s.apv>=3D5))){s.d.write('');if(!s.d.images[imn])s.ios" +"=3D0}}};s.mr=3Dfunction(sess,q,ta){var = s=3Dthis,ns=3Ds.visitorNamespace,unc" +"=3Ds.rep(s.fun,'_','-'),imn=3D's_i_'+s.fun,im,b,e,rs=3D'http'+(s.ssl?'s= ://ssl.':" +"'://std.')+'o.webmd.com/b/ss/'+s.un+'/1/H.1-pdv-2/'+sess+'?[AQB]&nd" +"h=3D1'+(q?q:'')+(s.q?s.q:'')+'&[AQE]';if(s.isie&&!s.ismac){if(s.apv>5" +".5)rs=3Ds.fl(rs,4095);else = rs=3Ds.fl(rs,2047)}if(s.ios){im=3Ds.wd[imn]?s." +"wd[imn]:s.d.images[imn];if(!im)im=3Ds.wd[imn]=3Dnew = Image;im.src=3Drs;if(" +"rs.indexOf('&pe=3D')>=3D0&&(!ta||ta=3D=3D'_self'||ta=3D=3D'_top'||(s.wd= .name&&t" +"a=3D=3Ds.wd.name))){b=3De=3Dnew = Date;while(e.getTime()-b.getTime()<500)e=3Dne" +"w Date}return ''}return ''};s.gg=3Dfunction(v){var s=3Dthis;return = s.wd['s_'+" +"v]};s.glf=3Dfunction(t,a){if(t.substring(0,2)=3D=3D's_')t=3Dt.substring= (2);" +"var s=3Dthis,v=3Ds.gg(t);if(v)s[t]=3Dv};s.gl=3Dfunction(v){var = s=3Dthis;s.pt(" +"v,',','glf',0)};s.gv=3Dfunction(v){var s=3Dthis;return = s['vpm_'+v]?s['v" +"pv_'+v]:s[v]};s.havf=3Dfunction(t,a){var = s=3Dthis,b=3Dt.substring(0,4),x=3D" +"t.substring(4),n=3DparseInt(x),k=3D'g_'+t,m=3D'vpm_'+t,q=3Dt,v=3Ds.link= TrackV" +"ars,e=3Ds.linkTrackEvents;s[k]=3Ds.gv(t);if(s.lnk||s.eo){v=3Dv?v+','+s.= vl" +"_l:'';if(v&&!s.pt(v,',','isf',t))s[k]=3D'';if(t=3D=3D'events'&&e)s[k]=3D= s.f" +"s(s[k],e)}s[m]=3D0;if(t=3D=3D'pageURL')q=3D'g';else = if(t=3D=3D'referrer')q=3D'r';" +"else = if(t=3D=3D'charSet'){q=3D'ce';if(s[k]&&s.em=3D=3D2)s[k]=3D'UTF-8'}else = if(" +"t=3D=3D'visitorNamespace')q=3D'ns';else = if(t=3D=3D'cookieDomainPeriods')q=3D'cd" +"p';else if(t=3D=3D'cookieLifetime')q=3D'cl';else = if(t=3D=3D'visitVariableProv" +"ider')q=3D'vvp';else if(t=3D=3D'currencyCode')q=3D'cc';else = if(t=3D=3D'channel'" +")q=3D'ch';else if(t=3D=3D'campaign')q=3D'v0';else if(s.num(x)) = {if(b=3D=3D'prop" +"')q=3D'c'+n;else if(b=3D=3D'eVar')q=3D'v'+n;else = if(b=3D=3D'hier'){q=3D'h'+n;s[k]" +"=3Ds.fl(s[k],255)}}if(s[k]&&t!=3D'linkName'&&t!=3D'linkType')s.qav+=3D'= &'+q" +"+'=3D'+s.ape(s[k]);return ''};s.hav=3Dfunction(){var = s=3Dthis;s.qav=3D'';s." +"pt(s.vl_t,',','havf',0);return = s.qav};s.lnf=3Dfunction(t,h){t=3Dt?t.toL" +"owerCase():'';h=3Dh?h.toLowerCase():'';var = te=3Dt.indexOf('=3D');if(t&&te" +">0&&h.indexOf(t.substring(te+1))>=3D0)return t.substring(0,te);return" +" ''};s.ln=3Dfunction(h){var s=3Dthis,n=3Ds.linkNames;if(n)return = s.pt(n,'" +",','lnf',h);return = ''};s.ltdf=3Dfunction(t,h){t=3Dt?t.toLowerCase():'';" +"h=3Dh?h.toLowerCase():'';var = qi=3Dh.indexOf('?');h=3Dqi>=3D0?h.substring(0," +"qi):h;if(t&&h.substring(h.length-(t.length+1))=3D=3D'.'+t)return = 1;retu" +"rn = 0};s.ltef=3Dfunction(t,h){t=3Dt?t.toLowerCase():'';h=3Dh?h.toLowerCase" +"():'';if(t&&h.indexOf(t)>=3D0)return 1;return = 0};s.lt=3Dfunction(h){var" +" = s=3Dthis,lft=3Ds.linkDownloadFileTypes,lef=3Ds.linkExternalFilters,lif=3D= s" +".linkInternalFilters;lif=3Dlif?lif:s.wd.location.hostname;h=3Dh.toLower= " +"Case();if(s.trackDownloadLinks&&lft&&s.pt(lft,',','ltdf',h))return " +"'d';if(s.trackExternalLinks&&(lef||lif)&&(!lef||s.pt(lef,',','ltef'" +",h))&&(!lif||!s.pt(lif,',','ltef',h)))return 'e';return ''};s.lc=3Dne" +"w Function('e','var = s=3Ds_c_il['+s._in+'],b=3Ds.eh(this,\"onclick\");s." +"lnk=3Ds.co(this);s.t();s.lnk=3D0;if(b)return this[b](e);return = true');s" +".bc=3Dnew Function('e','var = s=3Ds_c_il['+s._in+'];if(s.d&&s.d.all&&s.d." +"all.cppXYctnr)return;s.eo=3De.srcElement?e.srcElement:e.target;s.t();" +"s.eo=3D0');s.ot=3Dfunction(o){var a=3Do.type,b=3Do.tagName;return = (a&&a.toU" +"pperCase?a:b&&b.toUpperCase?b:o.href?'A':'').toUpperCase()};s.oid=3Df" +"unction(o){var = s=3Dthis,t=3Ds.ot(o),p=3Do.protocol,c=3Do.onclick,n=3D'',x=3D0;i" +"f(!o.s_oid){if(o.href&&(t=3D=3D'A'||t=3D=3D'AREA')&&(!c||!p||p.toLowerC= ase(" +").indexOf('javascript')<0))n=3Do.href;else = if(c){n=3Ds.rep(s.rep(s.rep(" +"s.rep(''+c,\"\\r\",''),\"\\n\",''),\"\\t\",''),' ','');x=3D2}else if(" +"o.value&&(t=3D=3D'INPUT'||t=3D=3D'SUBMIT')){n=3Do.value;x=3D3}else = if(o.src&&t=3D" +"=3D'IMAGE')n=3Do.src;if(n){o.s_oid=3Ds.fl(n,100);o.s_oidt=3Dx}}return = o.s_o" +"id};s.rqf=3Dfunction(t,un){var = s=3Dthis,e=3Dt.indexOf('=3D'),u=3De>=3D0?','+t.s" +"ubstring(0,e)+',':'';return u&&u.indexOf(','+un+',')>=3D0?s.epa(t.sub" +"string(e+1)):''};s.rq=3Dfunction(un){var = s=3Dthis,c=3Dun.indexOf(','),v=3Ds" +".c_r('s_sq'),q=3D'';if(c<0)return s.pt(v,'&','rqf',un);return s.pt(un" +",',','rq',0)};s.sqp=3Dfunction(t,a){var = s=3Dthis,e=3Dt.indexOf('=3D'),q=3De<0" +"?'':s.epa(t.substring(e+1));s.sqq[q]=3D'';if(e>=3D0)s.pt(t.substring(0,= " +"e),',','sqs',q);return 0};s.sqs=3Dfunction(un,q){var = s=3Dthis;s.squ[un]" +"=3Dq;return 0};s.sq=3Dfunction(q){var = s=3Dthis,k=3D's_sq',v=3Ds.c_r(k),x,c=3D0;" +"s.sqq=3Dnew Object;s.squ=3Dnew = Object;s.sqq[q]=3D'';s.pt(v,'&','sqp',0);s" +".pt(s.un,',','sqs',q);v=3D'';for(x in = s.squ)s.sqq[s.squ[x]]+=3D(s.sqq[s" +".squ[x]]?',':'')+x;for(x in = s.sqq)if(x&&s.sqq[x]&&(x=3D=3Dq||c<2)){v+=3D(" +"v?'&':'')+s.sqq[x]+'=3D'+s.ape(x);c++}return s.c_w(k,v,0)};s.wdl=3Dnew = " +"Function('e','var = s=3Ds_c_il['+s._in+'],r=3Dtrue,b=3Ds.eh(s.wd,\"onload\"" +"),i,o,oc;if(b)r=3Dthis[b](e);for(i=3D0;i=3D0)&&oc.indexOf(\".tl(\")<0)s.eh(o,\"oncli" +"ck\",0,s.lc);}return r');s.wds=3Dfunction(){var = s=3Dthis;if(s.apv>3&&(!" +"s.isie||!s.ismac||s.apv>=3D5)){if(s.b&&s.b.attachEvent)s.b.attachEven" +"t('onclick',s.bc);else if(s.b&&s.b.addEventListener)s.b.addEventLis" +"tener('click',s.bc,false);else s.eh(s.wd,'onload',0,s.wdl)}};s.vs=3Df" +"unction(x){var = s=3Dthis,v=3Ds.visitorSampling,g=3Ds.visitorSamplingGroup," +"k=3D's_vsn_'+s.un+(g?'_'+g:''),n=3Ds.c_r(k),e=3Dnew = Date,y=3De.getYear();e." +"setYear(y+10+(y<1900?1900:0));if(v){v*=3D100;if(!n){if(!s.c_w(k,x,e))" +"return 0;n=3Dx}if(n%10000>v)return 0}return = 1};s.dyasmf=3Dfunction(t,m)" +"{if(t&&m&&m.indexOf(t)>=3D0)return 1;return = 0};s.dyasf=3Dfunction(t,m){" +"var s=3Dthis,i=3Dt?t.indexOf('=3D'):-1,n,x;if(i>=3D0&&m){var = n=3Dt.substring(" +"0,i),x=3Dt.substring(i+1);if(s.pt(x,',','dyasmf',m))return n}return 0" +"};s.uns=3Dfunction(){var = s=3Dthis,x=3Ds.dynamicAccountSelection,l=3Ds.dynam" +"icAccountList,m=3Ds.dynamicAccountMatch,n,i;s.un.toLowerCase();if(x&&" +"l){if(!m)m=3Ds.wd.location.host;if(!m.toLowerCase)m=3D''+m;l=3Dl.toLowe= rC" +"ase();m=3Dm.toLowerCase();n=3Ds.pt(l,';','dyasf',m);if(n)s.un=3Dn}i=3Ds= .un." +"indexOf(',');s.fun=3Di<0?s.un:s.un.substring(0,i)};s.t=3Dfunction(){var= " +" s=3Dthis,trk=3D1,tm=3Dnew = Date,sed=3DMath&&Math.random?Math.floor(Math.ran" +"dom()*10000000000000):tm.getTime(),sess=3D's'+Math.floor(tm.getTime()" +"/10800000)%10+sed,yr=3Dtm.getYear(),vt=3Dtm.getDate()+'/'+tm.getMonth()= " +"+'/'+(yr<1900?yr+1900:yr)+' '+tm.getHours()+':'+tm.getMinutes()+':'" +"+tm.getSeconds()+' '+tm.getDay()+' '+tm.getTimezoneOffset(),tfs=3Ds.g" +"tfs(),ta=3D'',q=3D'',qs=3D'';s.uns();if(!s.q){var = tl=3Dtfs.location,x=3D'',c=3D" +"'',v=3D'',p=3D'',bw=3D'',bh=3D'',j=3D'1.0',k=3Ds.c_w('s_cc','true',0)?'= Y':'N',h" +"p=3D'',ct=3D'',pn=3D0,ps;if(s.apv>=3D4)x=3Dscreen.width+'x'+screen.heig= ht;if(" +"s.isns||s.isopera){if(s.apv>=3D3){j=3D'1.1';v=3Ds.n.javaEnabled()?'Y':'= N'" +";if(s.apv>=3D4){j=3D'1.2';c=3Dscreen.pixelDepth;bw=3Ds.wd.innerWidth;bh= =3Ds.w" +"d.innerHeight;if(s.apv>=3D4.06)j=3D'1.3'}}s.pl=3Ds.n.plugins}else = if(s.is" +"ie){if(s.apv>=3D4){v=3Ds.n.javaEnabled()?'Y':'N';j=3D'1.2';c=3Dscreen.c= olor" +"Depth;if(s.apv>=3D5){bw=3Ds.d.documentElement.offsetWidth;bh=3Ds.d.docu= me" +"ntElement.offsetHeight;j=3D'1.3';if(!s.ismac&&s.b){s.b.addBehavior('#" +"default#homePage');hp=3Ds.b.isHomePage(tl)?\"Y\":\"N\";s.b.addBehavio" +"r('#default#clientCaps');ct=3Ds.b.connectionType}}}else = r=3D''}if(s.pl)" +"while(pn=3D0&&oc.indexOf(\".s_oc(\")<0)||oc.indexOf(\".tl" +"(\")>=3D0)return = ''}ta=3Do.target;h=3Do.href?o.href:'';i=3Dh.indexOf('?');h" +"=3Ds.linkLeaveQueryString||i<0?h:h.substring(0,i);l=3Ds.linkName?s.link= " +"Name:s.ln(h);t=3Ds.linkType?s.linkType.toLowerCase():s.lt(h);if(t&&(h" +"||l))q+=3D'&pe=3Dlnk_'+(t=3D=3D'd'||t=3D=3D'e'?s.ape(t):'o')+(h?'&pev1=3D= '+s.ape(" +"h):'')+(l?'&pev2=3D'+s.ape(l):'');else = trk=3D0;if(s.trackInlineStats){i" +"f(!p){p=3Ds.gv('pageURL');w=3D0}t=3Ds.ot(o);i=3Do.sourceIndex;if(s.gg('= obje" +"ctID')){n=3Ds.gg('objectID');x=3D1;i=3D1}if(p&&n&&t)qs=3D'&pid=3D'+s.ap= e(s.fl" +"(p,255))+(w?'&pidt=3D'+w:'')+'&oid=3D'+s.ape(s.fl(n,100))+(x?'&oidt=3D'= +x" +":'')+'&ot=3D'+s.ape(t)+(i?'&oi=3D'+i:'')}}if(!trk&&!qs)return '';var = co" +"de=3D'';if(trk&&s.vs(sed))code=3Ds.mr(sess,(vt?'&t=3D'+s.ape(vt):'')+s.= ha" +"v()+q+(qs?qs:s.rq(s.un)),ta);s.sq(trk?'':qs);s.lnk=3Ds.eo=3Ds.linkName=3D= " +"s.linkType=3Ds.wd.s_objectID=3D'';return = code};s.tl=3Dfunction(o,t,n){var" +" = s=3Dthis;s.lnk=3Ds.co(o);s.linkType=3Dt;s.linkName=3Dn;s.t()};s.ssl=3D(s.= wd." +"location.protocol.toLowerCase().indexOf('https')>=3D0);s.d=3Ddocument;s= " +".b=3Ds.d.body;s.n=3Dnavigator;s.u=3Ds.n.userAgent;s.ns6=3Ds.u.indexOf('= Nets" +"cape6/');var apn=3Ds.n.appName,v=3Ds.n.appVersion,ie=3Dv.indexOf('MSIE = ')" +",i;if(v.indexOf('Opera')>=3D0||s.u.indexOf('Opera')>=3D0)apn=3D'Opera';= s." +"isie=3D(apn=3D=3D'Microsoft Internet = Explorer');s.isns=3D(apn=3D=3D'Netscape');" +"s.isopera=3D(apn=3D=3D'Opera');s.ismac=3D(s.u.indexOf('Mac')>=3D0);if(i= e>0){s" +".apv=3DparseInt(i=3Dv.substring(ie+5));if(s.apv>3)s.apv=3DparseFloat(i)= }e" +"lse if(s.ns6>0)s.apv=3DparseFloat(s.u.substring(s.ns6+10));else s.apv" +"=3DparseFloat(v);s.em=3D0;if(String.fromCharCode){i=3Descape(String.fro= mC" +"harCode(256)).toUpperCase();s.em=3D(i=3D=3D'%C4%80'?2:(i=3D=3D'%U0100'?= 1:0))}" +"s.un=3Dun;s.uns();s.vl_l=3D'charSet,visitorNamespace,cookieDomainPeriod= " +"s,cookieLifetime,visitVariableProvider,pageName,pageURL,referrer,cu" +"rrencyCode,purchaseID';s.vl_t=3Ds.vl_l+',channel,server,pageType,camp" +"aign,state,zip,events,products,linkName,linkType';for(var n=3D1;n<51;" +"n++)s.vl_t+=3D',prop'+n+',eVar'+n+',hier'+n;s.vl_g=3Ds.vl_t+',trackDown= " +"loadLinks,trackExternalLinks,trackInlineStats,linkLeaveQueryString," +"linkDownloadFileTypes,linkExternalFilters,linkInternalFilters,linkN" +"ames';if(pg)s.gl(s.vl_g);if(!ss){s.wds();s.ca()}}", l=3Dwindow.s_c_il,n=3Dnavigator,u=3Dn.userAgent,v=3Dn.appVersion,e=3Dv.in= dexOf( 'MSIE = '),m=3Du.indexOf('Netscape6/'),a,i,s;if(l)for(i=3D0;i0){a=3DparseInt(i=3Dv.substring(e +5));if(a>3)a=3DparseFloat(i)}else = if(m>0)a=3DparseFloat(u.substring(m+10) );else a=3DparseFloat(v);if(a>=3D5&&v.indexOf('Opera')<0&&u.indexOf( 'Opera')<0){eval(c);return new s_c(un,pg,ss)}else s=3Ds_c2f(c);return s( un,pg,ss)} if (s_not_pageview=3D=3D"n") {var = s_code=3Ds_md.t();if(s_code)document.write(s_code);} ------=_NextPart_000_0000_01C7F153.77C901F0--

Medscape

References

Related Links

Author Information

Information from Industry